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RESEARCH ABSTRACT 
 
N. Rajalakshmi*, Prof. Dina Rani**, Mrs. Sheeja*** 
*M.Sc(N)., II – Year Student, ** Principal, ***HOD, Department of Medical Surgical 
Nursing Shanmuga College of Nursing, Salem at the time of doing the study in October 
2016. 
ABSTRACT: Background - In modern medical practice, more than 60% of patients 
receive intravenous therapy during their hospitalization. Medication, fluids, nutrition, and 
blood products can all be given via the intravenous route. Peripheral veins are the most 
common intravenous access method in the hospitals. The problems associated with the 
peripheral Intravenous catheters are kinking, occlusion of the catheter itself, developing a clot 
or an infection at the venous insertion site (phlebitis). Method –A quantitative evaluative 
research approach, quasi experimental post-test only control group design was used. The 
sample size was 45, 15 in each experimental group I, experimental group II and control group 
were selected using non probability purposive sampling technique. Initially the researcher got 
permission from concerned authority. The written consent was obtained from the samples. 
The tools used were, Performa of demographic variable, structured rating scale to assess the 
patency of peripheral intravenous cannula. Heparinised saline flush was administered to 
experimental group I, 10 units of heparin in 2ml saline was given for 4 days twice daily after 
the administration of medication from the first day and within 12 hours of intravenous 
cannulation and 2ml of normal saline was given to experimental group II, for 4 days twice 
daily after the administration of medication from the first day and within 12 hours of 
intravenous cannulation. Result – The findings showed that there is a significant difference in 
the mean score of patency of peripheral intravenous cannula between experimental group I, 
experimental group II and control group, there is no significant association between the post 
test level of patency of peripheral intravenous cannula among samples in experimental group 
I with their selected demographic variable (age, size of cannula and site of cannula insertion), 
there is a significant association between the post test level of patency of peripheral 
intravenous cannula among samples in experimental group II with their age. Conclusion- 
Both heparinised saline and normal saline was found to be effective in maintaining the 
patency of peripheral intravenous cannula.                                                                 
Keywords: Heparinised saline, Normal saline, Patency of peripheral intravenous cannula 
*************************************************************************** 
INTRODUCTION: Peripheral intravenous cannulation is the most common method 
used for intravenous therapy in the hospitals; however it can be associated with some 
complications like hematoma, phlebitis, pain, frequent blockage and infections. In almost all 
cases reported, about 4.0% to 60% of patients develop infiltration and extravasation and about 
2.3%-67% of the patients develop phlebitis during their hospitalization, which will lead to the 
blockage of peripheral intravenous cannulas. 
 STATEMENT OF THE PROBLEM: A comparative study to evaluate the efficacy 
of heparinised saline and normal saline flush on patency of peripheral intravenous cannula 
among patients with medical conditions in selected hospital at Salem. 
OBJECTIVES: (1)To assess and compare the mean post test score of patency of 
peripheral intravenous cannula among Experimental group-I (Heparinised Saline) and control 
group. (2) To assess and compare the mean post test score of patency of peripheral 
intravenous cannula among Experimental group-II (Normal Saline) and control group. (3) To 
assess and compare the mean post test score of patency of peripheral intravenous cannula 
between Experimental group-I and Experimental group-II. (4) To find association between 
the post-test levels of patency of peripheral intravenous cannula among the Experimental 
group-I and Experimental group–II with their selected demographic variables (Age, Size of 
Cannula, site of cannula insertion). 
RESEARCH HYPOTHESES (level of significance at p<0.05): H1-There is a 
significant difference in the mean post test score of patency of peripheral intravenous cannula 
between Experimental group–I (Heparinised Saline) and control group. H2- There is a 
significant difference in mean post test score of patency of peripheral intravenous cannula 
between Experimental group–II (Normal Saline) and control group. H3- There is a significant 
difference in mean post test score of patency of peripheral intravenous cannula between 
Experimental group–I (Heparinised Saline) and Experimental group-II (Normal Saline). H4-
There is a significant association between post-test level of patency of peripheral intravenous 
cannula in Experimental group-I with their selected demographic variables (age, size of 
cannula, site of cannula insertion). H5: There is a significant association between post-test 
level of patency of peripheral intravenous cannula in Experimental group-II with their 
selected demographic variables (Age, Size of cannula, Site of cannula insertion). 
METHODS: (1) Heparinised saline: It is prepared by adding 0.5ml of heparin 
[5000 units in 5ml] with 100ml of 0.9% sodium chloride solution. After mixing the solution 
well 2ml of solution [10 units of heparin] is taken and flushed into the intravenous cannula 
twice daily (morning and evening) after administration of prescribed medications for 4 days 
from the first day and within 12 hrs of intravenous line cannula insertion. (2) Normal saline: 
It is a sterile solution which is commercially available in the concentration of 0.9gm of 
sodium chloride in 100 ml normal saline. From that 2ml of normal saline is taken and flushed 
into the intravenous line cannula twice daily (morning and evening) after administration of 
prescribed medications for 4 days from the first day and within 12 hrs of intravenous cannula 
insertion. (3) Patency of peripheral intravenous cannula: The patency of intravenous 
cannula is referred to as a state or quality of being open, expanded or unblocked in vein and 
allows the treatment to go freely into the vein. 
 Conceptual framework used in this study was Imogene King’s goal attainment theory. 
A quantitative study with evaluative approach, quasi experimental post-test only control 
group design was used. The study was conducted in Shanmuga hospital, Salem. The sample 
size was 45. Using purposive sampling technique, 15 samples were selected in each group i.e 
experimental group I, experimental group II, and control group. Researcher got written 
permission from the concerned authority and obtained consent from the samples. Data 
collection was done from 24.03.2016 to 14.05.2016. Selected intervention was provided to 
experimental group I and experimental group II. Intravenous site was assessed daily 2 times 
using structured rating scale to assess the patency of peripheral intravenous cannula. 
FINDINGS: (1) Demographic variables – Regarding the age of the samples in 
experimental group I majority 6(40%) were in the age group of 41 – 50 years. In experimental 
group II majority 6(40%) were in the age group of 31–40 years. In control group majority 
7(46.67%) were in the age group of 41 – 50 years. Regarding the gender in experimental 
group I majority 8(53.33%) were male. In experimental group II majority 9(60%) were male. 
In control group majority 8(53.33%) were female. Regarding the educational status in 
experimental group I majority 6(40%) had primary education. In experimental group II 
majority 6(40%) had higher secondary education. In control group majority 7(46.67%) had 
higher secondary education. Regarding the ward in experimental group I majority 8(53.33%) 
were admitted in Male medical ward. In experimental group II majority 9(60%) were 
admitted in Male medical ward. In control group majority 9(60%) were admitted in Female 
medical ward. Regarding the patient status in experimental group I majority 7(46.67%) were 
in the status of bed mobility. In experimental group II majority 8(53.33%) were in the status 
of bed mobility. In control group majority 7(46.67%) were in the status of bed mobility. 
Regarding the no of hospitalization in experimental group I majority 7(46.67%) were 
admitted for the first time. In experimental group II majority 6(40%) were admitted for the 
first time. In control group majority 6(40%) were admitted for the first time. Regarding the 
size of cannula in experimental group I majority 11(73.33%) had size of cannula as 20G. In 
experimental group II majority 13(86.67%) had size of cannula as 20G. In control group 
majority 12(80%) had size of cannula as 20G. Regarding the site of cannula insertion in 
experimental group I majority 11(73.33%) had their intravenous cannulation in left hand. I n 
experimental group II majority 12(80%) had their intravenous cannulation in left hand. In 
control group majority 12(80%) had their intravenous cannulation in left hand. Regarding the 
classification drug infused all 15(100%) in experimental group I, experimental group II and 
control group had antibiotics and antacids. 
(II). Findings related to post-test level of patency of peripheral intravenous cannula 
among samples. 
In experimental group I, 15(100%) had adequate patency on day 1. On day 2, 
majority 14(93.33%) had adequate patency. On day 3, majority 12(80%) had adequate 
patency. In experimental group II, 15(100%) had adequate patency on day1. on day 2, 
majority 13(86.67%) had adequate patency. On day 3, majority 12(80%) had adequate 
patency. In control group, all 15(100%) had adequate patency on day1. On day 2, majority 
9(60%) had adequate patency. On day 3, majority 6(40%) had moderately adequate patency. 
Fig-1: Column diagram shows the percentage distribution of post-test (day 4) level of patency of 
peripheral intravenous cannula among samples in experimental group I, Experimental group II 
and Control group. 
 
On day 4 in experimental group I, majority 11(73.33%) had adequate patency, 
2(13.33%) had moderately adequate patency and 2(13.33%) had inadequate patency. In 
experimental group II, 11(73.33%) had adequate patency, 3(20%) had moderately adequate 
patency and 1(33.3%) had inadequate patency. Whereas in control group, majority 9(60%) 
had inadequate patency, 3(20%) had moderately adequate patency and 3(20%) had adequate 
patency. 
III. Effectiveness of heparinised saline and normal saline on patency of peripheral 
intravenous cannula among samples. 
Table-1: Effectiveness of heparinised saline and normal saline on patency of peripheral 
intravenous cannula.       n=45(15+15+15) 
Group Mean S.D Unpaired 't' Value 
Experimental group I 1.33 0.71 
t =2.582* 
Control group 2.07 0.89 
Experimental group II 1.23 0.54 
t =3.167* 
Control group 2.07 0.89 
Experimental group I 1.33 0.71 
    t =0.431(NS) 
Experimental group II 1.23 0.54 
P<0.05 level of significant         N.S-not significant  
  
The above table -1 describes the mean score of patency of peripheral intravenous 
cannula in experimental group I was 1.33±0.71 and the mean score in experimental group II 
was 1.23±0.54 and the mean score in control group was 2.07±0.89. The calculated unpaired‘t’ 
value for experimental group I and control group was t=2.582 which was found to be 
statistically significant at p<0.05 level. The calculated unpaired‘t’ value for experimental 
group II and control group was t=3.167 which was found to be statistically significant at 
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p<0.05 level. The calculated unpaired’t’ value for experimental group I and experimental 
group II was t=0.431 which was found to be statistically not significant at p<0.05 level. 
Hence the research hypothesis H1 was accepted, H2 was accepted and null hypothesis H03 was 
accepted. 
            IV. Findings related to post test level of patency of peripheral intravenous 
cannula among samples in experimental group I and experimental group II with their 
selected demographic variables.  
Experimental group I-The chi-square value of post test level of patency of peripheral 
intravenous cannula with the age was (3.98), with size of cannula is (3.15), with site of 
cannula insertion is (0.84) which is less than the table value(12.59) which indicates no 
significant association at p<0.05 level of significance. Hence the research hypothesis H4 
[H04(a) was accepted,H04(b) was accepted and H04(c) was accepted].      
Experimental group II-The chi-square value of post test level of patency peripheral 
intravenous cannula with the age was (16.69), which is greater than the table value (12.59) 
which indicates there is a significant association between the experimental group II and age.  
The chi-square value of post test level of patency peripheral intravenous cannula with size of 
cannula is (0.83), with site of cannula insertion is (5.15) which is less than the table 
value(9.49) Which indicates no significant association at p<0.05 level of significance. Hence 
the research hypothesis H5 [H5(a) was accepted,H05(b) was accepted and H05(c) was accepted]. 
           DISCUSSION: Present study was supported by various other studies such as a study 
was conducted by Jonker M.A, etal (2010) to assess the effectiveness of heparinised saline 
flush and normal saline flush in maintaining the patency of central venous devices. The study 
result revealed that the heparinised saline flush is effective in decreasing the thrombotic 
occlusions of central venous access devices than the normal saline flush. A study was 
conducted by HeidariGorji MA, etal (2015) to assess the effectiveness of normal saline and 
heparinised saline flush in maintaining the patency of central venous catheters. The result 
revealed that the normal saline is effective in maintaining the patency of central venous 
catheters than the heparinised saline.  
           LIMITATIONS: (1) Few of the samples got discharged in between data collection 
period, so they were considered as attrition. (2) Re-cannulation was done for few samples on 
second, third day and fourth day in control group which influenced the results of the study. 
CONCLUSION: Both normal saline flush and heparinised saline flush is effective in 
maintaining the patency of peripheral intravenous cannula. Normal saline can be used as an 
alternative flush solution instead of heparinised saline solution to provide a cost effective 
care. The patients will experience minimal pain and will maintain the patency of intravenous 
cannulas during the intravenous therapies by flushing the intravenous cannulas in between the 
medication administration. It will also reduce the work strain of the nurses in terms of re-
inserting the intravenous cannulas. 
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CHAPTER I 
 
INTRODUCTION 
Be the change that you wish to see in the world 
-Mahatma Gandhi 
 
In modern medical practice, more than 60% of patients are 
receiving intravenous therapy during their hospitalization. Medication, 
fluids, nutrition, and blood products can all be given through the 
intravenous route, either through peripheral or central. Peripheral veins 
are the most common intravenous access method in the hospitals for a 
peripheral intravenous cannulation to give intravenous therapy. 
Compared with other route of administration, intravenous route is the 
fastest way to deliver fluids and medication throughout the body.                                    
(Kalpana khanal, 2013) 
 
Peripheral intravenous cannulas are usually considered a low risk; 
however it can be associated with some complications like hematoma, 
phlebitis, pain, frequent blockage and infections. The holistic assessment 
of the patient should be done on regular basis to prevent these 
complications. If the patient is not on continuous infusion in an inpatient 
setting, minimum six hourly assessments is necessary to prevent the 
complications and to maintain the patency of peripheral intravenous 
cannulas. Patients who are unstable and have the signs and symptoms of 
complications would be assessed more frequently. Hourly assessment of 
intravenous site and rate of infusion should be done when the patient is 
receiving continuous IV infusion. (www. rch.org.au)                                                                          
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A patent Intravenous line is one that is correctly placed and allows 
the treatment to flow directly into the patient's vein. Once the Intravenous 
line is in place, the nurse should check for patency of the line by inserting 
a syringe filled with saline solution, into the cannula and check for 
appropriate flow. During this process, the nurse should check for 
resistance, which can indicate blockage, and pain or swelling of the skin 
at the site of the Intravenous line, if intravenous line is not patent, either 
upon initial insertion or over the course of the treatment, and then the 
cannula should be removed and reinserted in another spot. (www.ehow. 
com)                                                                                                             
 
Maintenance of patency in peripheral intravenous device is 
important to reduce the discomfort and expense of replacement. It is 
common practice to flush the catheters with solutions of various strengths 
of heparin in saline (0.9%sodium chloride solution), before and after use 
(phlebotomy or drug administration), in order to reduce the risk of clots 
forming in the lumen and hence to maintain their patency. (UK 
Medicines Information, 2012)  
 
The problems associated with the peripheral Intravenous catheters 
are kinking, occlusion of the catheter itself, developing a clot or an 
infection at the venous insertion site (phlebitis). When the catheter 
becomes dislodged from the vein, it allows the medication and fluids into 
subcutaneous tissue (infiltration or extravasation), or air maybe 
introduced into the vein (air embolism). During the time of cannula 
insertion, the traumatized tissues release chemicals in response to the 
injury. Among these histamines which dilate the vein and surrounding 
vessels increasing blood flow to that area and also increases the 
permeability of the vessel wall enabling fluid and proteins to migrate to 
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the area from the surrounding tissues. This will lead to complications like 
infiltration, extravasation, and phlebitis. About 4.0-60% of the patients 
develops infiltration and extravasation and about 2.3-67% of the patients 
develops phlebitis during their hospitalization. (H.Patil, L.M.Sams, 
2014) 
 
Anticoagulant flush solutions are used widely to prevent catheter 
thrombosis. Because thrombi and fibrin deposits on catheters might serve 
as a nidus for microbial colonization of intravascular catheters, the use of 
anticoagulants might have a role in the prevention of catheter related 
blood stream infections. To prevent phlebitis and catheter-related 
infections Scheduled replacement of intravascular catheters should be 
proposed. Studies of short peripheral venous catheters indicate that the 
incidence of thrombophlebitis and bacterial colonization of catheters 
increases when catheters are left in place >72 hours. However, rates of 
phlebitis are not substantially different in peripheral catheters left in place 
72 hours compared with 96 hours. phlebitis and catheter colonization are 
have been associated with an increased risk for catheter-related infection, 
the short peripheral catheter sites commonly are rotated at 72--96-hour 
intervals to reduce both the risk for infection and patient discomfort 
associated with phlebitis. (CDC Guidelines 2015)           
                                                                                       
Flushing and locking of intravenous catheters are essential in the 
prevention of occlusion. The clinical sign of an occlusion is catheter 
malfunction and flushing is strongly recommended to ensure a well-
functioning of catheter. Flushing techniques and sufficient flushing 
volumes are important matters in adequate flushing in all catheter types. 
If a catheter is not in use, it is locked. For years, it has been thought that 
the catheter has to be filled with an anticoagulant to prevent catheter 
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occlusion. Heparin has played a key role in locking venous catheters. 
However, the high number of risks associated with heparin forces us to 
look for alternatives. Sodium chloride (0.9%) was also already introduced 
as locking solution in peripheral cannulas. Recently, a 0.9% sodium 
chloride lock has also been investigated in other types of catheters. 
Thrombolytic agents have also been studied as a locking solution because 
their antithrombotic effect was suggested as superior to heparin. The 
effective locking solution will depend on the catheter type and the 
patient’s condition. (Godelieve Alice Goossens, 2015)            
                                                                                      
Heparin is a naturally occurring anticoagulant produced by 
basophils and mast cells. Heparin acts as an anticoagulant, preventing the 
formation of clots and extension of existing clots within the blood. 
Heparin does not break down the clots that have already formed (unlike 
tissue plasminogen activator), it allows the body's natural clot lysis 
mechanisms to work normally to break down clots that have formed. 
Heparin binds to the enzyme inhibitor antithrombin III (AT), causing a 
conformational change that result in its activation through an increase in 
the flexibility of its reactive site loop.  The activated AT then inactivates 
thrombin and other proteases involved in blood clotting, most notably 
factor Xa. The rate of inactivation of these proteases by AT can increase 
by up to 1000-fold due to the binding of heparin.  Heparin is generally 
used for anticoagulation. It is given parenterally because it is not 
absorbed from the gut, due to its high negative charge and large size. It 
can be injected intravenously or subcutaneously; intramuscular injections 
are avoided because of the potential for forming hematomas. Heparin is 
on the World Health Organization's List of Essential Medicines, the most 
important medications needed in a basic health system.                                                                               
(www.wikipedia.com)                                                                       
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Normal Saline is a sterile, nonpyrogenic solution for fluid and 
electrolyte replenishment. It contains no antimicrobial agents. It is a 
isotonic volume expander. The pH of the normal saline is 5.0 (4.5 to 7.0). 
It contains 9 g/L Sodium Chloride with an osmolality of 308 m 
Osmole/L.  It contains 154 mEq/L Sodium and Chloride. The other name 
for normal saline is 0.9% Sodium Chloride Solution which contains 9.0g 
of salt per litter (0.90%).  (www.wikipedia.com) 
 
1.1 NEED FOR THE STUDY 
Heparinised saline flush vs Normal saline flush has been the major 
topic in discussion among the health care professionals for effectiveness 
to maintain the peripheral intravenous cannula patency. There is a 
controversial aspect concerning the method of choice for maintaining the 
patency of peripheral intermittent intravenous catheters. Some institutes 
use a dilution of heparin for this purpose, whereas many others use a 
small amount of normal saline flush. So, it would be worthwhile to look 
for the best available evidence for this. (Maria Mitsiou, 2008) 
 
Bertoglio. S, etal, (2012), conducted a retrospective observational 
cohort study with 610 vascular devices at National Institute for Cancer 
Research, IST Genova, and Italy. In heparinised saline group 297 samples 
were included and then in normal saline group 313 samples were 
included. The study result showed that there was no significant difference 
in between two groups in survival of vascular devices. So the researcher 
concluded that the normal saline seems to be as effective as heparinised 
saline for keeping patent vascular device. 
 
Elsevier (2009), did a randomized double blind controlled trial to 
investigate the efficacy of normal saline versus heparin saline in 
maintaining the patency of intravenous catheter among 150 children of 
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paediatric unit at United States. In that, Group I received normal saline 
flush (n=77) whereas Group II received heparin saline flush (n=73). The 
result showed that 72% of children were recovered from blockage during 
normal saline flush. Thus researcher concluded that the normal saline 
flush was effective in maintaining the patency of intravenous catheter 
than the heparinised saline. 
 
Visanu Thamlikitkul & Artit Indranoi. (2006), conducted a 
study among patients admitted to medical ward at Sir raj Hospital, 
Thailand. The study sites were ten medical wards containing two hundred 
and forty beds. Samples were selected and randomized into group I and 
group II. Heparinized saline was given to group I and normal saline was 
given to group II as a flushing agent. The results showed that the normal 
saline was effective in maintaining the patency of peripheral venous 
catheters in compared with the heparinised saline. 
 
Intravenous drug administration is common in hospitalised 
patients. If the daily volume of infusion is less, and needed intermittently, 
during the gap time the intravenous catheter may occlude with blood clot 
which may lead to thrombo-emboli, severe pain may occur during 
subsequent infusions as the clot forcefully dislodges from the lumen and 
even blockage of the catheter so early, this needs selection of new site. To 
prevent all these complications maintaining the patency is the best choice. 
 
Student researcher during her clinical practices had experienced 
that there is lack of practices regarding the intravenous cannula lock in 
between the drug administration among patients, which affects the 
patency of intravenous cannula frequently in patients receiving 
intermittent medications. Thus it leads to recannulation within short 
duration and also unnecessary expenditure, strain and pain to the patients.  
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The investigator felt the need to conduct study in order to find out  
the most effective method in maintaining the patency of peripheral 
intravenous cannula. The cost effective care is also one of the main 
concepts of quality of nursing care. The cost effective management 
should necessarily be carried out to maintain the patency of peripheral 
intravenous cannula.  
 
Hence the researcher selected two interventions that is heparinised 
saline flush and normal saline flush for maintaining the patency of 
peripheral intravenous cannula. 
 
1.2 STATEMENT OF THE PROBLEM 
 A comparative study to evaluate the efficacy of heparinised saline 
and normal saline flush on patency of peripheral intravenous cannula 
among patients with medical conditions in selected hospital at Salem. 
 
1.3 OBJECTIVES 
1. To assess and compare the mean post test score of patency of 
peripheral intravenous cannula among Experimental group-I 
(Heparinised Saline) and control group. 
2. To assess and compare the mean post test score of patency of 
peripheral intravenous cannula among Experimental group-II 
(Normal Saline) and control group. 
3. To assess and compare the mean post test score of patency of 
peripheral intravenous cannula between Experimental group-I 
and Experimental group-II. 
4. To find association between the post-test levels of patency of 
peripheral intravenous cannula among the Experimental group-I 
and Experimental group–II with their selected demographic 
variables (Age, Size of Cannula, site of cannula insertion). 
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1.4 RESEARCH HYPOTHESES :( Level of significance P < 0.05) 
H1: There is a significant difference in the mean post test score of 
patency of peripheral intravenous cannula between Experimental 
group–I (Heparinised Saline) and control group. 
H2:  There is a significant difference in mean post test score of patency 
of peripheral intravenous cannula between Experimental group–II 
(Normal Saline) and control group. 
H3:  There is a significant difference in mean post test score of patency 
of peripheral intravenous cannula between Experimental group–I 
(Heparinised Saline) and Experimental group-II (Normal Saline) 
H4: There is a significant association between post-test level of patency 
of peripheral intravenous cannula in Experimental group-I with 
their selected demographic variables (Age, Size of Cannula, site of 
cannula insertion) 
H4 (a): There is a significant association between post-test level of 
patency of peripheral intravenous cannula among 
Experimental group-I with their age. 
H4 (b): There is a significant association between post-test level of 
patency of peripheral intravenous cannula among 
Experimental group-I  and size of cannula. 
H4(c): There is a significant association between post-test level of 
patency of peripheral intravenous cannula among 
Experimental group-I and Site of cannula insertion. 
H5:  There is a significant association between post-test level of patency 
of peripheral intravenous cannula in Experimental group-II with 
their selected demographic variables (Age, Size of cannula, Site of 
cannula insertion) 
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H5(a): There is a significant association between post-test level of 
patency of peripheral intravenous cannula among 
Experimental group-II with their age. 
H5(b):There is a significant association between post-test level of 
patency of peripheral intravenous cannula among 
Experimental group-II and size of cannula. 
H5(c): There is a significant association between post-test level of 
patency of peripheral intravenous cannula among 
Experimental group-II and site of cannula insertion 
 
1.5 OPERATIONAL DEFINITION 
1. Effectiveness: 
Effectiveness refers to the extent to which the selected intervention 
maintains the patency of peripheral intravenous cannula has manifested 
by longer duration in the post test scores assessed using structured rating 
scale to assess the patency of peripheral intravenous cannula. 
  
2. Patency: 
  The patency of intravenous cannula is referred to as a state or 
quality of being open, expanded or unblocked in vein. 
 
3. Normal Saline:  
It is a sterile solution which is commercially available in the 
concentration of 0.9gm of sodium chloride in 100 ml normal saline. From 
that 2ml of normal saline is taken and flushed into the intravenous line 
cannula twice daily (morning and evening) after administration of 
prescribed medications for 4 days from the first day and within 12 hrs of 
intravenous cannula insertion.  
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4. Heparinised Saline:  
Heparinised saline is prepared by adding 0.5ml of heparin [5000 
units in 5ml] with 100ml of 0.9% sodium chloride solution. After mixing 
the solution well 2ml of solution [10 units of heparin] is taken and 
flushed into the intravenous cannula twice daily (morning and evening) 
after administration of prescribed medications for 4 days from the first 
day and within 12 hrs of intravenous line cannula insertion. 
 
5. Peripheral Intravenous Cannula:  
It refers to a short, thin, plastic tube called a catheter that goes 
through the skin and into a vein.  
 
1.6 ASSUMPTIONS: 
1. If intravenous cannula is not used continuously, it may get blocked. 
2. Intravenous cannula block may be reduced by periodical flushing. 
3. Heparin saline flush would be effective in maintaining the patency 
of peripheral intravenous cannula. 
4. Normal saline flush would be effective in maintaining the patency 
of peripheral intravenous cannula. 
 
1.7 DELIMITATIONS:  
The study is delimited to, 
     1. Patients having medical conditions only.  
2. Patients having 18G, 20G, 22G intravenous cannula only. 
3. Seven weeks period of data collection only. 
4. 45 samples. 
5. Shanmuga Hospital at Salem. 
 
 
 
11 
 
1.8 ETHICAL CONSIDERATION: 
1. Written permission was obtained from human ethical committee of 
Shanmuga College of nursing, Salem. 
2. Written permission was obtained from the concerned hospital 
authorities where the study is going to be conducted.  
3. Informed written consent was obtained from the samples enrolled 
in the study. 
4. All information was kept confidential and used only for the present 
study. 
1.9. CONCEPTUAL FRAMEWORK BASED ON IMOGENE 
KING’S GOAL ATTAINMENT THEORY. 
The study is based on Imogene King’s Goal Attainment theory 
which is most relevant to the present study to assess the effectiveness of 
heparinised saline and normal saline flush for maintaining patency of 
intravenous cannula among samples admitted in selected hospital in 
Salem. In this study the researcher and the samples mutually sets the goal. 
The researcher prepared, modified conceptual framework based on 
Imogene King’s Goal Attainment Theory.  
 
Perception: 
Perception is a process by which people translates sensory 
impression into coherent and unified manner to view the world around 
them. In this study the researcher perceived that the development of 
inadequate patency is more common among samples undergoing 
intravenous cannulation. 
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Judgement: 
The ability to judge and make a decision or form an opinion 
objectively, authoritatively and wisely, especially in matters affecting 
action. In this study the researcher judges the need for certain measures to 
maintain the patency of peripheral intravenous cannula among samples. 
 
Action: 
Each member of the group makes a judgement and thereby action 
follows to attain the goal. In this study the researcher identifies two 
measures to maintain patency of cannula. i.e.,heparinised saline and 
normal saline. 
 
Mutual Goal Setting: 
It is a process that leads to goal attainment. It is a dynamic process 
by which goal directed choice of perceived alternatives is made acted 
upon by the individuals or groups to answer a question and attain a goal. 
In this study the researcher and the samples understand their goal and 
action mutually. The main goal of this study is to maintain the patency of 
intravenous line cannula among samples. 
 
Reaction: 
Reaction is the individual plan together and moves towards goal 
attainment. In this study the researcher gets the concern from the samples 
who are at risk of developing inadequate patency of intravenous cannula. 
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Intervention: 
It is the action of two or more persons in mutual presents a 
sequence of verbal behaviours that are goal directed. In this study the 
researcher administers the 2 planned measures i.e., heparinised saline and 
the normal saline to maintain the patency of peripheral intravenous line 
cannula in two different groups. 
 
Transaction: 
It is the process of interaction in which human beings communicate 
with the environment to achieve goal that are valued towards goal 
directed human behaviours. In this study the researcher assess the patency 
of intravenous cannula using structured rating scale. 
 
Goal Attainment: 
In this study the researcher’s goal is to maintain the patency of 
intravenous line cannula, if the goal is attained then the patency will be 
maintained and if the goal is not attained then the reassessment is done, 
but the reassessment is not included in this study. 
 
SUMMARY 
This chapter dealt with the introduction, need for the study, 
statement of the problem, objectives, hypotheses, operational definitions, 
assumptions, delimitations, ethical consideration and conceptual 
framework based on Imogene King’s Goal Attainment Theory. 
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Perception: Lack of patency is 
the common problem in patients 
with intravenous cannula. 
Judgement: There is a need for 
certain measures for maintaining 
the patency of intravenous line 
cannula. 
Action: Researcher identified two 
measures i.e heparinised saline 
and normal saline flush for 
maintaining the patency of 
intravenous cannula. 
Action: Willingness of the 
samples with intravenous cannula 
to participate in the study. 
Judgement: The samples realize 
the need to undergo the 
intervention to maintain the 
patency of cannula. 
Perception: Samples are 
perceived them as a risk to 
develop inadequate patency of IV 
cannula. 
R
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S
A
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P
L
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The researcher plans for 
implementing the 
intervention i.e., 
heparinised saline flush 
and normal saline flush 
in intravenous line 
cannula on samples for 
maintaining the 
adequate patency. 
The samples gave 
consent to 
participate in 
research study. 
Group I: Flushing of 
intravenous line cannula 
with heparinised saline 
twice daily for 4 days 
from the first day of 
cannulation. 
 
Group II: Flushing of 
intravenous line cannula 
with normal saline twice 
daily for 4 days from 
the first day of 
cannulation. 
Assess the level of 
patency of 
intravenous line 
cannula using 
structured rating 
scale. 
TRANSACTION INTERACTION REACTION MUTUAL GOAL 
SETTING 
Goal attained 
Patency of intravenous 
cannula is adequate. 
Goal not attained 
Patency of intravenous 
cannula is inadequate. 
FIG-1.1: CONCEPTUAL FRAMEWORK BASED ON IMOGENE KING’S GOAL ATTAINMENT MODEL (1997) 
APPLIED ON MAINTAINING PATENCY OF INTRAVENOUS CANNULA 
Reassessment (not included in this study) 
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CHAPTER – II 
REVIEW OF LITERATURE 
Literature review is a laborious task, but it is essential if the 
research process is to be successful. One of the most satisfying aspects of 
the literature review is the contribution it makes to the new knowledge, 
insight and general scholarship of the researcher. 
 
 A literature review is the body of text that aims to review the 
critical points of knowledge on a particular topic of research. Polit and 
Beck, (2004) 
 
 In the present study, the review of literature was organised under 
the following headings: 
Section–I: Studies related to patency and related complications of 
intravenous line cannulation. 
Section- II: Studies related to heparinised saline flush for maintaining the 
patency of intravenous cannula. 
Section-III: Studies related to normal saline flush for maintaining the 
patency of intravenous cannula. 
Section-IV: Studies related to heparinised saline and normal saline flush 
for maintaining the patency of intravenous cannula. 
Section-V: Studies related to application of Imogene King’s Goal 
Attainment Theory. 
 
SECTION-I: STUDIES RELATED TO PATENCY AND RELATED 
COMPLICATIONS OF INTRAVENOUS LINE CANNULATION. 
Abolfotouh M.A, Salam M, etal, (2014), conducted a study in 
various wards of king Abdullah International Medical Research Center, 
Riyadh, Saudi Arabia to investigate the incidence and predicators of 
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peripheral intravenous catheter induced complications. About 359 
patients were selected for the study. The results revealed the rate of 
complications such as phlebitis ranked 17.6%, pain 7.6%, leaking 3.9%, 
dislodgement 2.4%, extravasations and occlusions 0.5% each.   
 
Meenakashi Agnihotri, (2011) conducted a study in emergency 
departments of Nehru Hospital; Chandigarh. Totally 168 samples were 
selected for the study. The study results revealed that the incidence of 
infiltration and phlebitis as 31.5% and 29.8% respectively. It was found 
that the peripheral intravenous cannula insertions with aseptic technique 
and ineffective handling and management of cannula, longer duration of 
cannula placement along with the use of IV infusion sets for more than 
24hours, administration of large volumes of crystalloids and colloids at 
high flow rates through the peripheral intravenous cannulae were the 
most important risk factors for the development of infiltration and 
phlebitis and also it was found that 36.5% cannulae not flushed after 
insertion developed phlebitis. 
 
Prabhjot, et.al, (2011) did a study to assess the risk factors leading 
to phlebitis in emergency outpatient department of a tertiary care hospital. 
Totally 200 samples were included in the study. The study result showed 
that there was a significant relationship between the phlebitis and 
duration of cannula in situ, administration of antibiotics.  
 
SECTION – II: STUDIES RELATED TO HEPARINISED SALINE 
FLUSH FOR MAINTAINING THE PATENCY OF 
INTRAVENOUS CANNULA. 
Upadhyay A, et.al, (2015), conducted a study on 120 neonates (60 
in normal saline group and 60 in heparin saline group), the study results 
showed the mean functional duration of catheter was more (71hours) in 
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heparin saline group as compared with normal saline group(57 hours). 
The researcher concluded that the heparinised saline flush is effective in 
maintaining the functional duration of peripheral intravenous cannula 
than the normal saline flush. 
 
Ziyaeifard  M, Alizadehasl A, Aghdaii N, et.al, (2014), did a 
randomized controlled trial in Rajaie heart center; Tehran, Iran to 
compare the efficacy of normal saline with heparinised saline to maintain 
the patency of arterial catheter and central venous pressure monitoring 
catheter. Totally 100 patients were randomized into 50 in heparinised 
saline and 50 in normal saline flush solutions. The study results showed 
that there was no significant incidence of obstruction and changes in all 
other parameter between two groups. The researcher concluded that both 
flush solutions are effective in preventing the catheter occlusion. 
 
Tripathi S, et.al, (2008), conducted a study on 88 samples in a 
general paediatric ward of Lady Harding Medical College and Kalawati 
Saran Children’s Hospital. Samples were randomly assigned to 
experimental group and control group. Heparinised saline was used for 
experimental group and splint was applied to control group. The study 
results revealed that there was a statistically significant increase in the 
duration of patency of intravenous cannula with the use of heparinised 
saline flush. The research concluded that the heparinised saline is 
effective in maintain the patency of intravenous cannula. 
 
SECTION – III: STUDIES RELATED TO NORMAL SALINE 
FLUSH FOR MAINTAINING THE PATENCY OF 
INTRAVENOUS CANNULA. 
 Alizadehasl A, et.al, (2015), did a randomized clinical trial on 100 
patients undergoing elective cardiac surgery in Rajaje Cardiac vascular 
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Medical Research Center; Tehran, Iran. Patients were randomized to use 
heparinised saline (50 samples) and normal saline (50 samples) flush to 
maintain the patency of arterial catheter after operation. The study results 
revealed that there was no significant difference between heparinised and 
saline groups in maintaining the patency of arterial catheters and 
acceptable wave forms. Hence the researcher concluded that the normal 
saline can be used instead of heparinised saline to maintain the patency of 
arterial catheters. 
Raziyeh Ghadiriyan, et.al, (2013), conducted a study on patients 
with peripheral venous catheter admitted in a cardiac care units in 
selected hospital of Isfahan university of medical sciences, Iran. Totally 
88 samples were selected and randomly divided into two groups (normal 
saline group and control group). The study results showed that there was 
a significant difference in between two groups regarding the degree of 
phlebitis. The percentage of phlebitis in control group was 88.6% and 
normal saline group was 43.2%. Hence the researcher concluded normal 
saline is effective in maintaining the patency of peripheral venous 
catheters. 
Wang R, Luo O, He L, et.al, (2012), did a prospective controlled 
trial to find the effectiveness of preservative free 0.9% sodium chloride 
for flushing and locking peripheral intravenous access device. Totally178 
and 181 patients were selected with gastroenterology and hepatic diseases 
for heparinised saline and normal saline group respectively. The results 
showed that normal saline neither shortened the duration of peripheral 
intravenous cannula maintenance nor increases the proportion of 
abnormal withdrawal. The researcher concluded that the normal saline 
solution is as effective and safe conventional than heparinised saline 
solution. 
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Hephzibah Alexander, (2010), conducted a systematic review of 
the study on heparin versus normal saline as a flush solution. The 
electronic database of Ovid, Pub-Med, the Cochrane Library and the 
Cochrane Database of Systematic Reviews (CDSR) was searched for 
heparin or normal saline (either singly or in combinations). Relevant 
studies were critically appraised and evidence obtained, the findings 
indicate that it might be safer to use normal saline as it does not have the 
risks associated with heparin. For arterial catheters, majority of the 
available data suggest that heparin saline given as a continuous flush at 
low doses improved catheter patency. The result of the study revealed 
that normal saline can be used as an alternative to heparin in intravenous 
catheters. The researcher concluded that heparin as an intermittent flush 
was ineffective and normal saline was just as effective as and more 
efficacious than heparin. 
 
Maninder Kaur, et.al, (2006), conducted a study on 60 samples in 
Nehru Hospital, Chandigarh, to evaluate effectiveness of normal saline 
lock solution in maintaining the patency of intravenous cannula. Samples 
were randomly divided into normal saline group (30 samples) and control 
group (30 samples). The results revealed that the 96.7% cannulae were 
patent in normal saline group and 56.7% cannulae were patent in control 
group at the end of day 3. The researcher concluded that the normal saline 
lock is effective in maintaining the intravenous cannula. 
 
Fujita T, et.al, (2006), conducted a study to evaluate the effect of 
normal saline for flushing peripheral venous locks. Totally 321 patients 
were selected for the study. For the first two months period participants 
were received normal saline and for the next two months period the 
participants were received heparinised saline as a peripheral venous flush 
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solution. The study results revealed that there was no significant 
difference was found in the rates of phlebitis, extravasation and clotting 
in between two groups. Hence the researcher concluded that the normal 
saline is effective as heparinised saline in maintaining the peripheral 
venous locks. 
 
SECTION – IV: STUDIES RELATED TO HEPARINISED SALINE 
AND NORMAL SALINE FLUSH FOR MAINTAINING THE 
PATENCY OF INTRAVENOUS CANNULA. 
 H. Patil, Sams LM, (2014) conducted a Quasi experimental study  
among 40 patients at medical and surgical wards of AJ Hospital and 
Research Centre, Mangalore, to assess the effectiveness of heparinised 
saline vs normal saline in maintaining the patency of intravenous cannula. 
Samples were randomly divided into heparinised saline group and normal 
saline groups. Results revealed that the mean patency score of 
experimental group I in 72 hrs were 1.50 ± 0.51, 1.50. In experimental 
group II the mean patency score in72 hrs were 1.90 ± 0.55, 2. There was 
no significant difference in the patency scores in between two groups. 
The researcher concluded that the heparinised saline flush and normal 
flush was effective in maintaining the patency of peripheral intravenous 
lines. 
 
Patidar. AB, (2014) conducted a study among 75 patients at 
selected hospitals in Delhi to assess the efficacy of heparinised saline  and 
normal saline flush for maintaining the patency of peripheral intravenous 
cannula. Samples were assigned to heparinised saline group, normal 
saline group and control group and respective interventions was given for 
three days. Control group was not received any interventions. The results 
revealed that the duration of patency of intravenous line in control group 
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was (53 ± 19 hrs) and normal saline group was (64 ± 14 hrs) and heparin 
saline group was (66 ± 11 hrs). So there is no significant difference in 
duration of patency of intravenous cannula among normal saline and 
heparinised saline groups. The researcher concluded that normal saline is 
as effective as heparinised saline in maintaining the patency of 
intravenous cannula. 
 
Ling jia Goh (2011), Conducted a study in Neuro Science 
Intensive Care Unit, Singapore General Hospital; Singapore, to assess the 
effectiveness of heparinised saline and normal saline in maintaining the 
patency of Arterial and Central Venous Catheters. Totally 70 samples (36 
in NS group and 34 in HS group) were included in the study. The study 
results showed that the normal saline and heparinised saline both were 
maintained the patency of catheters up to 72 to 120 hours. The researcher 
concluded that the use of normal saline is effective simple and safe than 
the heparinised saline in maintaining the patency of arterial and central 
venous catheters.  
 
Francesco Vassallo (2010), conducted a study on 610 samples at 
the National Cancer Institute of Genova, to assess the efficacy of normal 
saline vs heparinised saline solutions for locking catheters of totally 
implantable long-term central vascular access devices in adult cancer 
patients. Samples were divided into heparinised saline group and normal 
saline group and respective interventions was given to both groups. The 
results of the study revealed that there was no significant statistical 
difference between two groups. The researcher concluded that normal 
saline solution can be used as an alternative to heparinised saline 
solutions for maintaining the patency of central vascular access device. 
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Vazquez. CM, et.al, (2010), did a systematic review using 
databases; Medline, cinahl, cuiden and Cochrane library. Two meta-
analysis and six RCTS were identified and analysed, results from one 
meta-analysis and two RCTS supported the use of heparin for 
maintaining the peripheral arterial catheter patency. In rest of the studies 
no significant difference were found in between saline and heparin group 
in maintaining the patency of arterial catheter. From this review it is 
concluded that the use of heparinised is not necessary and saline is 
effective in maintaining the patency of arterial catheters. 
 
Niesen KM, et.al, (2003), did a randomized double blind study at 
Academic Medical Centre in the Midwest. Totally 73 samples (pregnant 
women with 24 to 42 weeks) were selected and randomly assigned to 
heparinised saline and normal saline group. The study result showed no 
significant difference between two groups in intravenous lock patency 
and in phlebitis. So it is concluded that both were effective in maintaining 
the patency of peripheral intravenous cannulas. 
 
SECTION–V: STUDIES RELATED TO APPLICATION OF 
IMOGENE KING’S GOAL ATTAINMENT THEORY. 
 Alligod MR, (2010) Kings conceptual system and therapy of goal 
attainment provided a systematic approach to the though and action of 
nursing that has stood the test of the time with continuing utility for 
organizing the complex factors of health care. Following a brief overview 
of the conceptual system and theory of goal attainment, application to 
family health care is discuss and illustrated with the programs of research 
of three exemplar king’s scholars- family health care with a mentally-ill 
child, family healthcare with children with type, diabetes or asthma and 
family health when a family member has chronic obstruction pulmonary. 
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The scientific benefit and development progression of a theory driven 
program of research for practice is noted. Future studies are presented as 
well as additional source of king’s conceptual system and theory of goal 
attainment.  
 
Khurshid Khowaja, (2006), conducted a study to assess the 
effectiveness of implementing a clinical pathway for patients undergoing 
Trans urethral resection prostate at Aga Khan University Hospital, 
Pakistan. This study used King’s Interacting system framework and 
theory of Goal Attainment. Findings of the study showed a significant 
difference in variances and outcomes as a result of TURP clinical 
pathway intervention. The clinical pathway significantly improved the 
nursing and physician related variances and outcomes. Clinical pathway 
has provided opportunities of interaction and transaction among the 
health team also through clinical pathway health care team communicates 
patient care goals with each other. So it is concluded that King’s theory 
and framework provided direction for nursing practice by emphasising 
the processes of multi-disciplinary collaboration, communication, 
interaction, transaction and use of critical thinking. 
 
SUMMARY: 
 This chapter dealt with the review related to patency and related 
complications of intravenous cannulation, effect of heparinised saline on 
patency of intravenous cannula, effect of normal saline on patency of 
intravenous cannula, effect of heparinised saline vs normal saline on 
patency of intravenous cannula, and application of Imogene King’s Goal 
Attainment Theory. 
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CHAPTER – III 
 
METHODOLOGY 
  
 Methodology of research organizes all the components of study in 
a way that is most likely to lead to valid answers to the problems that 
have been posted. (Burns and Groove, 2002). 
 
This chapter deals with the description of  research approach and 
design, study setting, population, sample, criteria for sample selection, 
sampling technique, sample size, variables, data collection instrument, 
description of tool, validity and reliability of tool, pilot study, data 
collection procedure and plan for data analysis.  
 
3.1 RESEARCH APPROACH 
Research approach is the umbrella that covers the basic procedures 
for conducting research. (Treece and Treece 1996) 
  
 The selection of research approach is a basic procedure for 
conducting the research study. In view of the nature of the problem 
selected for the study and the objectives to be accomplished, the 
researcher has selected quantitative evaluative research approach. 
 
3.2 RESEARCH DESIGN 
Research design is the overall plan for addressing a research 
question including specification for enhancing the study integrity. 
Research design helps the researcher in selection of variables, their 
manipulation and control, observation to be made and type of statistical 
analysis to interpret the data. 
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The research design selected for the present study is quasi 
experimental post test only control group design. 
 
Groups Intervention 
Post Test 
 
Day1 
 
Day2 Day3 Day 4 
M E M E M E M E 
 
C 
 
- O1 O2 O3 O4 O5 O6 O7 O8 
 
E1 
 
X1 O1 O2 O3 O4 O5 O6 O7 O8 
 
E2 
 
X2 O1 O2 O3 O4 O5 O6 O7 O8 
Fig-3.1: Schematic representation of research design 
 
Keys: 
C  - Control group 
E1  -  Experimental group - 1 
E2  -  Experimental group – 2 
X1 - Administration of Heparinised Saline Flush. 
X2 - Administration of Normal Saline Flush. 
O1 to O8- Assessment of patency of peripheral intravenous line cannula in 
morning and evening for 4 days. 
 
3.3 RESEARCH SETTINGS  
Setting is the physical location in which data collection takes place.  
(Polit and Hungler, 2008) 
 
The study was conducted in Shanmuga hospital at Salem. It is a 
355 bedded multi-speciality hospital and it has separate Salem cancer 
institute with 50 beds. There are 4 floors and beds are distributed in 4 
floors. It has 3 ICU’s, 1 postoperative ward, 1emergency department, 
paediatric ward, labour ward and operation theatre with all advanced 
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equipment’s. It has the facilities like ECG, ECHO, EEG, CT scan, 
Ultrasound scan, Dialysis unit, X ray and laboratory with advanced 
technologies. 
 
3.4 DESCRIPTION OF VARIABLES  
Concepts which can take on different qualitative value are called 
variables. (Kothari. C.R, 2002) 
The variables under the study are the following, 
Independent variables: 
 The variable that is believed to care or influence the behaviour and 
ideas. (Polit and Hungler, 2008). 
 
In this study, independent variables are Heparinised saline and 
Normal saline flush to maintain the patency of peripheral intravenous 
cannula. 
 
Dependent variables: 
The dependent variable is the variable the researcher is interested 
in understanding explaining and preceding. (Polit and Hungler, 2008). 
 
In this study, the dependent variable is the patency of peripheral 
intravenous cannula. 
 
Demographic variables: 
Demographic variables are those variables that are present in 
research environment which may interfere with research findings by 
acting as unwanted independent variables. (Woods and Kahn, 1994). 
 
In this study it includes age, gender, ward, educational status, 
patient status, number of hospitalization, size of cannula, site of cannula 
insertion and classification of drug given through intravenous cannula.  
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3.5 POPULATION 
 The entire set of individuals or objects having the same or common 
characteristics. (Polit and Hungler, 2008). 
The population of the study is the patients admitted with medical 
conditions in shanmuga hospital Salem. 
 
3.6 SAMPLE 
A sample is a subset of the population selected to participate in the 
research study (Polit and Hungler, 2008) 
In this study samples are patients admitted with medical conditions 
and have undergone peripheral intravenous cannulation within 12hrs and 
having intravenous cannula of size 18G, 20G and 22G in Shanmuga 
hospital Salem. 
3.6.1 Sampling criteria 
Inclusion criteria: 
1. Patients who had intravenous line cannula within 12 hrs of 
insertion. 
2. Patients who are willing to participate in the study.  
3. Patients who are available during the period of data collection. 
4. Patients admitted in male medical ward and female medical ward. 
5. Patients who are getting only intermittent medications through 
intravenous cannula. 
Exclusion criteria 
1. Patients who are having bleeding disorders. 
2. Patients who are having severe hypertension. 
3. Patients admitted with surgical conditions. 
4. Patients who are already receiving heparin for other conditions. 
5. Patients receiving platelet inhibitor drugs like Aspirin, 
antihistamines, indomethacin and hydroxychloroquine. 
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3.6.2 Sampling technique  
Sampling technique is the method of selection of samples. (Polit 
and Beck, 2004) 
 
In this study the researcher selected the samples using non- 
probability purposive sampling technique. 
 
3.6.3 Sample size  
Sample size in the study was 45 among which 15 samples in 
control group, 15 samples in experimental group I (Heparinised saline) 
and 15 samples in experimental group II (Normal saline). 
 
3.7 DEVELOPMENT, DESCRIPTION, INTERPRETATION, 
VALIDITY AND RELIABILITY OF TOOL 
 The instruments selected in a research must be the vehicles that 
obtain best data for drawing conclusion to the study.  (Polit and Beck, 
2004) 
 
In this study the researcher has prepared and modified tool to 
collect data from the samples. The tools are, 
Tool-1: Demographic profile of the sample. 
Tool-2:  Structured rating scale to assess the patency of peripheral 
intravenous cannula. 
 
Tool-1: Demographic profile of the sample 
It dealt with demographical data which was used to collect the 
information about the patient. It includes age, gender, ward, educational 
status, no of hospitalization, patient status, size of peripheral intravenous 
cannula, site of intravenous cannula insertion, classification of drug 
infused through cannula. 
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Tool-2: Structured Rating scale to assess the patency of peripheral 
intravenous cannula. 
 The researcher prepared this tool with the help of review of 
literature and with guidance of experts. This tool consists of 12 questions 
which describes about the symptoms that is occurring while the patency 
is affected. Those symptoms were grouped into 4 aspects that were 
based on the intensity and severity. The maximum score is 3. Based on 
the group of symptoms shown by the samples score was given. If the 
score is 0-1the patency is adequate. If the score is 2 then the patency is 
moderately adequate. If the score is 3 then the patency is inadequate.   
 
PREPARATION OF INDEPENDENT VARIABLE 
Heparinised Saline [for experimental group-I] 
Heparinised saline was prepared by adding 0.5ml of heparin [5000 
units in 5ml] with 100ml of 0.9% sodium chloride solution. After mixing 
the solution well 2ml of solution [10 units of heparin] was taken and 
flushed into the intravenous cannula twice daily (morning and evening) 
after administration of prescribed medications for 4 days from the first 
day and within 12 hrs of intravenous cannula insertion. Intravenous site 
was assessed daily 2 times using structured rating scale for patency. 
 
Normal Saline [for experimental group-II] 
It is a sterile solution which is commercially available in the 
concentration of 0.9gm of sodium chloride in 100 ml normal saline. From 
that 2ml of normal saline was taken and flushed into the intravenous line 
cannula twice daily (morning and evening) after administration of 
prescribed medications for 4 days from the first day and within 12 hrs of 
intravenous cannula insertion. Intravenous site was assessed daily 2 times 
using structured rating scale for patency. 
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For Control group 
No intervention was given by the researcher, only the routine care 
from the nursing staff was provided as per the hospital protocol. 
Intravenous site was assessed daily 2 times for 4 days using structured 
rating scale for patency. 
 
3.8 CONTENT VALIDITY AND RELIABILITY 
The content validity refers to the degree to which an instrument 
measures, what it is supposed to be measure. (Polit and Hungler, 2008).  
 
The prepared tool and independent variables along with the 
statement of the problem, objectives and hypotheses and evaluation 
criteria was submitted to six experts and validity was obtained from them.  
(Four nursing experts and two medical experts). 
 
Reliability 
Reliability of research instrument is defined as the extent to which 
the instrument has the same result on repeated measures. (Polit and 
Hungler, 2008). 
 
Reliability of the tool was assessed by inter-rater reliability method 
by administering it to 5 samples. The reliability of the tool II structured 
rating scale to assess the patency tool was 0.98. 
 
3.9 PILOT STUDY 
The pilot study is a small scale version done in a preparation for 
main study. (Polit and Hungler, 2008).  
            The pilot study was conducted in Gobi hospital. Initially the 
researcher got written permission from the concerned authority after 
explaining the procedure and purpose of the study. The staff nurses of the 
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wards were oriented about the study and benefits of heparinised saline 
and normal saline flush in maintaining patency of intravenous cannula. 
Then the researcher selected 9 samples using non probability purposive 
sampling techniques. Written consent was obtained from the samples. 
 
 Three samples in each experimental group I, experimental group II 
and Control group was taken. In control group intravenous line cannula 
care was given as routine care by staff nurses and the patency was 
assessed by using rating scale from day 1 to day 4 at morning and 
evening. 
 
In Experimental group I (Heparinised saline) intravenous line 
cannula care was given with Heparinised saline 12th hourly (Morning and 
evening). The level of patency was assessed every day morning and 
evening using structured rating scale from day 1 to day 4. 
 
In Experimental group II (Normal saline) intravenous line cannula 
care was given with Normal saline 12th hourly (Morning and evening). 
The level of patency was assessed every day morning and evening using 
structured rating scale from day 1 to day 4. 
 
There is a significant difference found in the mean post test score 
of peripheral intravenous cannula between experimental group I 
(Heparinised saline), experimental group II (Normal saline) and control 
group. And there has no significant association found between the post 
test level of patency of peripheral intravenous cannula among samples 
with their selected demographic variables (age ,size of cannula, site of 
insertion) in experimental group I(Heparinised saline) and experimental 
group II (Normal saline). No modification was done after the pilot study 
at any level.               
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3.10 DATA COLLECTION PROCEDURE 
 Data collection is the gathering of information needed to address a 
research problem. (Polit and Hungler, 2008) 
 
The study was conducted in Shanmuga hospital from 24.03.2016 to 
14.05.2016.  Initially the researcher got written permission from the 
concerned hospital authority after explaining the procedure and purpose 
of the study. The staff nurses of the hospital were oriented about the study 
and benefits of heparinised saline and normal saline flush in maintaining 
the patency of intravenous cannula. Then the researcher selected 45 
samples using non probability purposive sampling techniques and based 
on the sampling criteria. Written consent was obtained from the samples. 
 
The researcher has collected the data from control group then 
experimental group I (Heparinised saline) and at last from experimental 
group II (Normal saline). The administration of Heparinised 
saline/Normal saline was done within 12 hours of intravenous 
cannulation. Assessment of intravenous cannulation site was done twice 
daily (morning and evening) from the first day onwards for 4 days using 
structured rating scale to assess the patency of peripheral intravenous 
cannula.  
 
Experimental group I had 15 samples and Heparinised saline was 
administered into the intravenous cannula twice daily (morning and 
evening) for 4 days after administering the prescribed medications from 
the first day and within 12hrs of intravenous cannula insertion. 
Intravenous site was assessed twice daily (morning and evening) for four 
days using structured rating scale to assess the patency of peripheral 
intravenous cannula.   
33 
 
 
Experimental group II had 15 samples and Normal saline was 
administered into the intravenous cannula twice daily (morning and 
evening) for 4 days after administering the prescribed medications from 
the first day and within 12hrs of intravenous cannula insertion. 
Intravenous site was assessed twice daily (morning and evening) for four 
days using structured rating scale to assess the patency of peripheral 
intravenous cannula.  
 
Control group had 15 samples and no intervention was given by the 
researcher, only the routine care from the nursing staffs was provided as 
per hospital protocol. Intravenous site was assessed twice daily (morning 
and evening) for four days using structured rating scale to assess the 
patency of peripheral intravenous cannula.    
 
3.11 PLANS FOR DATA ANALYSIS 
Analysis of quantitative data deals with information collected 
during research study, which can be quantified and statistical calculation, 
can be computed. (Sharma S 2011) 
 
The data obtained was analysed in terms of the objective of the 
study using descriptive (mean, standard deviation, mean score 
percentage) and inferential (Unpaired t test and chi square test) statistics. 
 
Tool-1: Demographic profile of the samples was analysed using 
frequency and percentage distribution. 
Tool-2: Structured rating scale to assess the level of patency of 
peripheral intravenous cannula was analysed using descriptive statistics 
like mean, standard deviation and inferential statistics like unpaired ‘t’ 
test and chi square test. 
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SUMMARY 
 This chapter dealt with methodology for the present study, it 
includes research approach, research design, research setting, population 
used in the study, sample and sampling technique, description of the 
tools, reliability and validity, pilot study, data collection procedure and 
plan for data analysis. 
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CHAPTER – IV 
 
DATA ANALYSIS AND INTERPRETATION 
 
This chapter deals with the analysis and interpretation of data 
collected from 45 samples admitted in a selected hospital at Salem, to 
assess the effectiveness of heparinised saline flush and normal saline 
flush in maintaining the patency of peripheral intravenous cannula. The 
data collected for the study was grouped and analysed as per the 
objectives set for the study. The findings drawn based on the descriptive 
and inferential statistical analysis are presented under the following 
sections. 
 
STATEMENT OF THE PROBLEM 
 A comparative study to evaluate the efficacy of heparinised saline 
and normal saline flush on patency of peripheral intravenous cannula 
among patients with medical conditions in selected hospital at Salem. 
 
OBJECTIVES 
1. To assess and compare the mean post test score of patency of 
peripheral intravenous cannula among Experimental group-I 
(Heparinised saline) and Control group. 
2. To assess and compare the mean post test score of patency of 
peripheral intravenous cannula among Experimental group-II 
(Normal saline) and control group. 
3. To assess and compare the mean post test score of patency of 
peripheral intravenous cannula between Experimental group-I and 
Experimental group-II. 
4. To find association between the post-test levels of patency of 
peripheral intravenous cannula among the Experimental group-I 
and Experimental group–II with their selected demographic 
variables (Age, Size of Cannula, site of cannula insertion). 
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RESEARCH HYPOTHESES :( Level of significance P < 0.05) 
H1: There is a significant difference in the mean post test score of 
patency of peripheral intravenous cannula between Experimental 
group–I (Heparinised Saline) and control group. 
H2: There is a significant difference in mean post test score of patency 
of peripheral intravenous cannula between Experimental group–II 
(Normal Saline) and control group. 
H3: There is a significant difference in mean post test score of patency 
of peripheral intravenous cannula between Experimental group–I 
(Heparinised Saline) and Experimental group-II (Normal Saline) 
H4: There is a significant association between post-test level of patency 
of peripheral intravenous cannula in Experimental group-I with 
their selected demographic variables (Age, Size of Cannula, site of 
cannula insertion) 
H4 (a): There is a significant association between post-test level of 
patency of peripheral intravenous cannula among 
Experimental group-I with their age. 
H4 (b): There is a significant association between post-test level of 
patency of peripheral intravenous cannula among 
Experimental group-I and size of cannula. 
H4(c): There is a significant association between post-test level of 
patency of peripheral intravenous cannula among 
Experimental group-I and Site of cannula insertion. 
H5:  There is a significant association between post-test level of patency 
of peripheral intravenous cannula in Experimental group-II with 
their selected demographic variables (Age, Size of cannula, Site of 
cannula insertion) 
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H5(a): There is a significant association between post-test level of 
patency of peripheral intravenous cannula among 
Experimental group-II with their age. 
H5(b):There is a significant association between post-test level of 
patency of peripheral intravenous cannula among 
Experimental group-II and size of cannula. 
H5(c): There is a significant association between post-test level of 
patency of peripheral intravenous cannula among 
Experimental group-II and site of cannula insertion 
 
4.1 ORGANIZATION OF DATA 
The findings of the study were grouped and analysed under the 
following sections.  
Section-A: Description of the demographic variables of samples. 
Section-B: Assessment of post-test level of patency of peripheral 
intravenous cannula among samples in experimental group I 
and experimental group II and control group. 
Section-C: Effectiveness of heparinised saline and normal saline on 
patency of peripheral intravenous cannula. 
Section-D: Association of post-test level of patency of intravenous line 
cannula among samples with their selected demographic 
variables in experimental group I (Heparinised saline) and 
experimental group II (Normal saline).  
 
4.1.1 SECTION-A: DESCRIPTION OF THE DEMOGRAPHIC 
VARIABLES. 
 This section deals with the details of the analysis about the 
distribution of the samples according to the frequency and percentage. 
The selected variables are age, gender, educational status, ward, patient 
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status, number of hospitalization, size of cannula, site of cannula insertion 
and classification of drug infused. 
 
Table-4.1:  Frequency and percentage distribution of demographic 
variables of samples     n1 = 15 ; n2 = 15; n3 = 15 
S NO 
  
Demographic 
variables 
Ex. I  
(Hep saline) 
Ex. II  
(Normal saline) 
Control 
group 
No % No % No % 
I Age             
a 21-30 3 20.00 2 13.33 3 20.00 
b 31-40 4 26.67 6 40.00 4 26.67 
c 41-50 6 40.00 5 33.33 7 46.67 
d 51-60 2 13.33 2 13.33 1 6.67 
II Gender             
a Male 8 53.33 9 60.00 7 46.67 
b Female 7 46.67 6 40.00 8 53.33 
III Educational status             
a No formal education 2 13.33 1 6.67 1 6.67 
b Primary education 6 40.00 5 33.33 5 33.33 
c Higher secondary 5 33.33 6 40.00 7 46.67 
d Graduate  2 13.33 3 20.00 2 13.33 
IV Ward       
 
    
a Male medical ward 8 53.33 9 60.00 7 46.67 
b Female medical ward 7 46.67 6 40.00 8 53.33 
V Patient status             
a Confined to bed 5 33.33 3 20.00 4 26.67 
b Bed mobility 7 46.67 8 53.33 7 46.67 
c Complete ambulation 3 20.00 4 26.67 4 26.67 
VI No of hospitalization             
a First time 7 46.67 6 40.00 6 40.00 
b Second time 5 33.33 4 26.67 4 26.67 
c Third time 2 13.33 3 20.00 4 26.67 
d More than three times 1 6.67 2 13.33 1 6.67 
VII Size of cannula             
a 18G 2 13.33 1 6.67 2 13.33 
b 20G 11 73.33 13 86.67 12 80.00 
c 22G 2 13.33 1 6.67 1 6.67 
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VIII 
Site of cannula 
insertion             
a Right hand 4 26.67 3 20.00 3 20.00 
b Left hand 11 73.33 12 80.00 12 80.00 
IX 
Classification of 
drug             
a Antibiotics 15 100 15 100 15 100 
b Antacids 15 100 15 100 15 100 
 
The table 4.1 shows that in the experimental group I (Heparinised 
saline), majority 6(40%) were in the age group of 41 – 50 years, 
8(53.33%) were male, 6(40%) had primary education, 8(53.33%) were 
admitted in Male medical ward, 7(46.67%) were in the status of bed 
mobility, 7(46.67%) were admitted for the first time, 11(73.33%) had 
their intravenous cannulation in left hand, 11(73.33%) had size of cannula 
as 20G and all 15(100%) have received antibiotics and antacids. 
 
Also it shows that in the experimental group II(Normal saline 
flush), majority 6(40%) were in the age group of 31–40 years, 9(60%) 
were male, 6(40%) had higher secondary education, 9(60%)were 
admitted in Male medical ward, 8(53.33%) were in the status of bed 
mobility, 6(40%) were admitted for the first time, 12(80%) had their 
intravenous cannulation in left hand, 13(86.67%) had size of cannula as 
20G and all 15(100%) have received antibiotics and antacids. 
 
Also it portrays that in the control group,  majority 7(46.67%) were 
in the age group of 41 – 50 years, 8(53.33%) were female, 7(46.67%) had 
higher secondary education, 8(53.33%) were admitted in Female medical 
ward, 7(46.67%) were in the status of bed mobility, 6(40%) were 
admitted for the first time, 12(80%) had their intravenous cannulation in 
left hand, 12(80%) had size of cannula as 20G and all 15(100%) %) have 
received antibiotics and antacids. 
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4.1.2 SECTION-B: ASSESSMENT OF POST-TEST LEVEL OF 
PATENCY OF PERIPHERAL INTRAVENOUS CANNULA 
AMONG SAMPLES IN EXPERIMENTAL GROUP I, 
EXPERIMENTAL GROUP II AND CONTROL GROUP. 
 This section deals with analysis of the post test level of patency of 
peripheral intravenous cannula among samples in experimental group I 
and experimental group II and control group. 
It is divided into following subheadings; 
a) Post test level of patency of peripheral intravenous cannula in 
experimental group I 
b) Post  test level of patency of peripheral intravenous cannula in 
experimental group II 
c) Post test level of patency of peripheral intravenous cannula in 
control group. 
d) Post test (day 4) level of patency of peripheral intravenous 
cannula among experimental group I, experimental group II and 
control group. 
a) The Post test assessment of patency of peripheral intravenous 
cannula was presented as day by day findings among experimental 
group I. 
Table-4.2: Frequency and percentage distribution of post test level of 
patency of peripheral intravenous cannula among samples in 
experimental group I (Heparinised saline).                n=15 
S No 
Patency of peripheral 
intravenous cannula 
Adequate 
patency 
Moderately 
adequate 
patency 
Inadequate 
patency 
    No % No % No % 
1 Day 1 15 100.00 0 0 0 0 
2 Day 2 14 93.33 1 6.67 0 0 
3 Day 3 12 80.00 3 20.00 0 0 
4 Day 4 11 73.33 2 13.33 2 13.33 
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 The table 4.2 shows that in the experimental group I, 15(100%) had 
adequate patency in day 1. In day 2, majority 14(93.33%) had adequate 
patency and 1(6.67%) had moderately adequate of patency. In day 3, 
majority 12(80%) had adequate patency and 3(20%) had moderately 
adequate patency. In day 4 majority 11(73.33%) had adequate patency, 
2(13.33%) had moderately adequate patency and 2(13.33%) had 
inadequate patency. 
 
b) The Post test assessment of patency of peripheral intravenous 
cannula was presented as day by day findings among experimental 
group II. 
Table- 4.3: Frequency and percentage distribution of post-test level 
of patency of peripheral intravenous cannula among samples in 
experimental group II (Normal saline).          n=15 
S NO 
Patency of peripheral 
intravenous cannula 
Adequate 
patency 
Moderately 
adequate 
patency 
Inadequate 
patency 
    No % No % No % 
1 Day 1 15 100.00 0 0 0 0 
2 Day 2 13 86.67 2 13.33 0 0 
3 Day 3 12 80.00 3 20.00 0 0 
4 Day 4 11 73.33 3 20.00 1 6.67 
  
The table 4.3 shows that in the experimental group II, 15(100%) 
had adequate patency in day 1. In day 2, majority 13(86.67%) had 
adequate patency and 2(13.33%) had moderately adequate of patency. In 
day 3, majority 12(80%) had adequate patency and 3(20%) had 
moderately adequate patency. In day 4, majority 11(73.33%) had 
adequate patency, 3(20%) had moderately adequate patency and 
1(6.67%) had inadequate patency. 
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c). The Post test assessment of patency of peripheral intravenous 
cannula was presented as day by day findings among control group.    
Table- 4.4: Frequency and percentage distribution of post-test level 
of patency of peripheral intravenous cannula among samples in 
control group.             n=15 
S No 
Patency of peripheral 
intravenous cannula 
Adequate 
patency 
Moderately 
adequate 
patency 
Inadequate 
patency 
    No % No % No % 
1 Day 1 15 100.00 0 0 0 0 
2 Day 2 9 60.00 3 20.00 3 20.00 
3 Day 3 4 26.67 6 40.00 5 33.33 
4 Day 4 3 20.00 3 20.00 9 60.00 
 
The table 4.4 shows that in the control group, 15(100%) had 
adequate patency in day1. In day 2, majority 9(60%) had adequate 
patency, 3(20%) had moderately adequate patency and 3(20%) had 
inadequate patency and have undergone re-cannulation. Whereas in day 
3, majority 6(40%) had moderately adequate patency, 4(26.67%) had 
adequate patency and 5(33.3%) had inadequate patency and have 
undergone re-cannulation. In day 4, 9(60%) had inadequate patency, 
3(20%) had moderately adequate patency and only 3(20%) had adequate 
patency. 9 samples have undergone re-cannulation on day 4. 
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d) The Post-test assessment of patency of peripheral intravenous 
cannula among Experimental group I, Experimental group II and 
Control group on Day 4.                    
 
 
Fig-4.1:  Column diagram shows percentage distribution of post-
test (day 4) level of patency of peripheral intravenous cannula 
among samples in experimental group I, Experimental group II 
and Control group 
 
The figure 4.1 shows that in the experimental group I, majority 
11(73.33%) had adequate patency, 2(13.33%) had moderately adequate 
patency and 2(13.33%) had inadequate patency. In experimental group II, 
11(73.33%) had adequate patency, 3(20%) had moderately adequate 
patency and 1(33.3%) had inadequate patency. Whereas in control group, 
majority 9(60%) had inadequate patency, 3(20%) had moderately 
adequate patency and 3(20%) had adequate patency.   
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4.1.3 SECTION-C: EFFECTIVENESS OF HEPARINISED SALINE 
FLUSH AND NORMAL SALINE FLUSH ON PATENCY OF 
PERIPHERAL INTRAVENOUS CANNULA AMONG SAMPLES. 
 This section dealt with analysis and comparison of post test level of 
patency of peripheral intravenous cannula among samples between 
experimental group I (heparinised saline), experimental group II (normal 
saline) and control group using descriptive statistics i.e. Mean, standard 
deviation and inferential statistics i.e. unpaired “t” test with  p<0.05 level 
of significance to test research hypothesis. 
This section is divided under following subheading; 
a)  Analysis and comparison of post test level of patency of peripheral 
intravenous cannula between experimental group I (Heparinised 
saline) and control group. 
b) Analysis and comparison of post test level of patency of peripheral 
intravenous cannula between experimental group II (Normal 
saline) and control group.  
c) Analysis and comparison of post test level of patency of peripheral 
intravenous cannula between experimental group I (Heparinised 
saline) and experimental group II (Normal saline). 
 
a) Comparison of post test level of patency of peripheral intravenous 
cannula between experimental group I (Heparinised saline) and 
control group 
Hypothesis H1: 
There is a significant difference in the mean post test score of 
patency of peripheral intravenous cannula between experimental group I 
(heparinised saline) and control group 
To test the hypothesis H1 the following null hypothesis H01 was 
formulated. 
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Null Hypothesis H01: 
There is no significant difference in the mean post test score of 
patency of peripheral intravenous cannula between experimental group I 
(heparinised saline) and control group 
In order to test the hypothesis H1 the researcher used unpaired ‘t’ 
test. The following table shows the finding. 
 
Table–4.5: Comparison of post test level of patency of peripheral 
intravenous cannula between experimental group I (Heparinised 
saline) and control group.       n=30(15+15) 
S No Groups Mean SD 
Unpaired 't' 
value 
 
1 
 
Experimental group I 1.3 0.7 
t=2.58* 
 
2 
 
Control group 2.07 0.89 
*p<0.05 level of significance       d.f=28,     Table value – 2.048 
  
The table 4.5 shows the mean and SD post test score of patency of 
peripheral intravenous cannula in experimental group I was 1.3 ± 0.7 and 
the mean and SD score in control group was 2.07 ± 0.89. The calculated 
unpaired ‘t’ value was t = 2.58 which was found to be statistically 
significant at p < 0.05 level. 
The above findings clearly indicate that there was significant 
difference in the level of patency of peripheral intravenous cannula in the 
experimental group I after the administration of heparinised saline and the 
control group. Hence the hypothesis H1 was accepted and null hypothesis 
H01 was rejected. 
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b) Comparison of post test level of patency of peripheral intravenous 
cannula between experimental group II (Normal saline) and control 
group. 
Hypothesis H2:  
There is a significant difference in the mean post test score of 
patency of peripheral intravenous cannula between experimental group II 
(Normal saline) and control group. 
 
To test the hypothesis H2 the following null hypothesis H02 was 
formulated. 
 
Null Hypothesis H02: 
There is no significant difference in the mean post test score of 
patency of peripheral intravenous cannula between experimental group II 
(Normal saline) and control group. 
 
In order to test the hypothesis H2 the researcher used unpaired ‘t’ 
test. The following table shows the finding.  
  
Table–4.6: Comparison of post test level of patency of peripheral 
intravenous cannula between experimental group II (Normal saline) 
and control group.       n=30(15+15) 
S No Group Mean SD Unpaired 't' value 
 
1 
 
Experimental group II 1.2 0.54 
t=3.167* 
2 
 
Control group 
 
2.07 0.89 
*p<0.05 level of significance   d.f=28,    Table value – 2.048 
 
The table 4.6 shows the mean and SD post test score of patency of 
peripheral intravenous cannula in experimental group II was 1.2 ± 0.54 
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and the mean and SD score in control group was 2.07 ± 0.89. The 
calculated unpaired ‘t’ value was t = 3.167 which was found to be 
statistically significant at p < 0.05 level. 
 
The above findings clearly indicate that there was significant 
difference in the level of patency of peripheral intravenous cannula in the 
experimental group II after the administration of normal saline and the 
control group. Hence the hypothesis H2 was accepted and null hypothesis 
H02 was rejected. 
 
c. Comparison of post test level of patency of peripheral intravenous 
cannula between experimental group I (Heparinised saline) and 
experimental group II (Normal saline)  
Hypothesis H3:  
There is a significant difference in the mean post test score of 
patency of peripheral intravenous cannula between experimental group I 
(Heparinised Saline) and experimental group II (Normal saline). 
 
To test the hypothesis H3 the following null hypothesis H03 was 
formulated. 
 
Null Hypothesis H03: 
There is no significant difference in the mean post test score of 
patency of peripheral intravenous cannula between experimental group I 
(Heparinised Saline) and experimental group II (Normal saline) 
 
In order to test the hypothesis H3 the researcher used unpaired‘t’ 
test. The following table shows the finding. 
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Table–4.7: Comparison of post test level of patency of peripheral 
intravenous cannula between experimental group I (Heparinised 
Saline) and experimental group II (Normal saline).     n=30(15+15) 
S No Group Mean SD Unpaired 't' value 
 
1 
 
Experimental group I 1.3 0.7 
t=0.43 N.S 
 
2 
 
Experimental group II 1.2 0.54 
N.S- not significant d.f=28, Table value – 2.048 
 
The table 4.7 shows  the mean and SD post test score of patency of 
peripheral intravenous cannula in experimental group I was 1.3 ± 0.7 and 
the mean and SD score in experimental group II was 1.2 ± 0.54. The 
calculated unpaired ‘t’ value was t = 0.43 which was found to be 
statistically not significant at p < 0.05 level. 
The above findings clearly indicate that there was no significant 
difference in the level of patency of peripheral intravenous cannula in the 
experimental group I after the administration of heparinised saline and the 
experimental group II after the administration of normal saline. Hence 
both has same effect in maintaining the patency of peripheral intravenous 
cannula. Hence the hypothesis H03 was rejected and null hypothesis H03 
was accepted. 
4.1.4 SECTION-D: ASSOCIATION OF POST-TEST LEVEL OF 
PATENCY OF PERIPHERAL INTRAVENOUS CANNULA 
AMONG SAMPLES WITH THEIR SELECTED 
DEMOGRAPHICAL VARIABLES IN EXPERIMENTAL GROUP I 
(HEPARINISED SALINE) AND EXPERIMENTAL GROUP II 
(NORMAL SALINE). 
This section dealt with the association of post test level of patency 
of peripheral intravenous cannula among samples between experimental 
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group I (Heparinised saline) and experimental group II (Normal saline) 
using chi-square test. The cross tabulation analysis was employed 
effectively and the result of chi-square analysis was observed.  
 
This section is divided under the following sub heading. 
A. Association of post test level of patency of peripheral intravenous 
cannula among samples with their selected demographic variables 
in experimental group I (Heparinised saline). 
B. Association of post test level of patency of peripheral intravenous 
cannula among samples with their selected demographic variables 
in experimental group II (Normal saline). 
 
A. Association of post test level of patency of peripheral intravenous 
cannula among samples with their selected demographic variables in 
experimental group I (Heparinised saline). 
This section dealt with the association of post test level of patency of 
peripheral intravenous cannula among samples in experimental group I 
using chi-square test. The cross tabulation analysis was employed 
effectively and the result of chi-square analysis was observed. 
 
Hypothesis H4:  
There is a significant association between the post test level of 
patency of peripheral intravenous cannula among experimental group I 
(Heparinised Saline) with their selected demographic variables(Age, Size 
of cannula and Site of cannula insertion) 
 
To test the hypothesis H4 the following null hypothesis H04 was 
formulated. 
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Null Hypothesis H04: 
There is no significant association between the post test level of 
patency of peripheral intravenous cannula among experimental group I 
(Heparinised saline) with their selected demographic variables (Age, Size 
of cannula and Site of cannula insertion) 
Hence, further it is divided into three sub headings 
a) Association between experimental group I and age of the sample 
b) Association between experimental group I and size of cannula 
c) Association between experimental group I and site of cannula 
insertion 
a. Association of post-test (day 4) level of patency of peripheral 
intravenous cannula among experimental group I (Heparinised 
saline) with their age. 
Hypothesis H4(a): 
There is a significant association between the post test level of 
patency of peripheral intravenous cannula among experimental group I 
(Heparinised saline) with their age 
 
To test the hypothesis H4(a) the following null hypothesis H04(a) was 
formulated. 
 
Null Hypothesis H04(a): 
There is no significant association between the post test level of 
patency of peripheral intravenous cannula among experimental group I 
(Heparinised saline) with their age. 
 
In order to test the hypothesis H4(a) the researcher used chi-square 
test. The following table shows the finding. 
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Table–4.8: Association of post-test (day 4) level of patency of 
peripheral intravenous cannula among experimental group I 
(Heparinised saline) with their age.         n=15 
S.NO 
Demographic    
variables 
Adequate                 
patency         
(0-1) 
Moderately 
adequate   
patency (2) 
Inadequate  
(3) 
Chi-square     
value 
(X 2)                 
No % No % No  % 
I Age in years             
3.98                  
N.S 
a) 21-30 3 20.00 0 0 0 0 
b) 31-40 2 13.33 1 6.7 1 6.7 
c) 41-50 3 20.00 2 13.33 1 6.7 
d) 51-60 2 13.33 0 0 0 0 
N.S - Not significant p<0.05 level of significance,   d.f = 6, Table value = 12.59 
 
Data presented in table 4.8 Shows that calculated chi-square value 
is less than the table value, which indicates that there is no significant 
association between the post test level of patency of peripheral 
intravenous cannula among experimental group I (Heparinised saline) and 
age at p<0.05 level. Hence the hypothesis H4(a) was rejected and null 
hypothesis H04(a)  was accepted. 
 
b). Association of post-test (day 4) level of patency of peripheral 
intravenous cannula among experimental group I (Heparinised 
saline) with size of cannula. 
Hypothesis H4(b): 
There is a significant association between the post test level of 
patency of peripheral intravenous cannula among experimental group I 
(Heparinised saline) with size of cannula. 
 
To test the hypothesis H4(b) the following null hypothesis H04(b) was 
formulated. 
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Null Hypothesis H04(b): 
There is no significant association between the post test level of 
patency of peripheral intravenous cannula among experimental group I 
(Heparinised saline) with size of cannula. 
 
In order to test the hypothesis H4(b) the researcher used chi-square 
test. The following table shows the finding. 
 
Table–4.9: Association of post-test (day 4) level of patency of 
peripheral intravenous cannula among experimental group I 
(Heparinised saline) with size of cannula.        n=15 
S.NO 
Demographic    
variables 
Adequate                 
patency         
(0-1) 
Moderately 
adequate 
patency (2) 
Inadequate  
(3) Chi-square     
value(X 2) 
No % No % No  % 
II Size of cannula             
3.15                  
N.S 
a) 18G 2 13.33 0 0 0 0 
b) 20G 6 40.00 3 20.00 1 6.7 
c) 22G 2 13.33 0 0 1 6.7 
N.S - Not significant p<0.05 level of significance,  d.f = 4,    Table value = 9.49 
 
Data presented in table 4.9 shows that calculated chi-square value 
is less than the table value, which indicates that there is no significant 
association between the post test level of patency of peripheral 
intravenous cannula among experimental group I (Heparinised saline) and 
size of cannula at p<0.05 level. Hence the hypothesis H4(b)  was rejected 
and null hypothesis H04(b)  was accepted. 
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c. Association of post-test (day 4) level of patency of peripheral 
intravenous cannula among experimental group I (Heparinised 
saline) with site of cannula insertion 
Hypothesis H4(c): 
There is a significant association between the post test level of 
patency of peripheral intravenous cannula among experimental group I 
(Heparinised saline) with site of cannula insertion. 
 
To test the hypothesis H4(c) the following null hypothesis H04(c) was 
formulated. 
 
Null Hypothesis H04(c): 
There is no significant association between the post test level of 
patency of peripheral intravenous cannula among experimental group I 
(Heparinised saline) with site of cannula insertion. 
 
In order to test the hypothesis H4(c) the researcher used chi-square 
test. The following table shows the finding. 
 
Table–4.10: Association of post-test (day 4) level of patency of 
peripheral intravenous cannula among experimental group I 
(Heparinised saline) with site of cannula insertion.       n=15 
S.NO 
Demographic    
variables 
Adequate                 
patency         
(0-1) 
Moderately 
adequate 
patency (2) 
Inadequate  
(3) 
Chi-square     
value 
(X 2) 
No % No % No  % 
III 
Site of cannula 
insertion             0.84                                  
N.S a) Right Hand 3 20.00 1 6.7 0 0 
b) Left Hand 7 46.67 2 13.33 2 13.33 
N.S - Not significant p<0.05 level of significance,  d.f=6,  Table value = 12.59 
54 
 
Data presented in table 4.10 Shows that calculated chi-square value 
is less than the table value, which indicates that there is no significant 
association between the post test level of patency of peripheral 
intravenous cannula among experimental group I (Heparinised saline) and 
site of cannula insertion at p<0.05 level. Hence the hypothesis H4(c) was 
rejected and null hypothesis H04(c) was accepted. 
 
B. Association of post test level of patency of peripheral intravenous 
cannula among samples with their selected demographic variables in 
experimental group II (Normal saline) 
This section dealt with the association of post test level of patency 
of peripheral intravenous cannula among samples in experimental group 
II using chi-square test. The cross tabulation analysis was employed 
effectively and the result of chi-square analysis was observed. 
 
Hypothesis H5:  
There is a significant association between the post test level of 
score of patency of peripheral intravenous cannula in experimental group 
II (Normal saline) with their selected demographic variables(Age, Size of 
cannula and Site of cannula insertion) 
 
To test the hypothesis H5 the following null hypothesis H05 was 
formulated. 
 
Null Hypothesis H05: 
There is no significant association between the post test level of 
patency of peripheral intravenous cannula among experimental group II 
(Normal saline) with their selected demographic variables(Age, Size of 
cannula and Site of cannula insertion) 
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Hence, further it is divided into three sub headings 
a) Association between experimental group II and age of the 
sample 
b) Association between experimental group II and size of cannula 
c) Association between experimental group II and site of cannula 
insertion 
 
a. Association of post-test (day 4) level of patency of peripheral 
intravenous cannula among experimental group II (Normal saline) 
with their age. 
Hypothesis H5(a): 
There is a significant association between the post test level of 
patency of peripheral intravenous cannula among experimental group II 
(Normal saline) with their age. 
 
To test the hypothesis H5(a) the following null hypothesis H05(a) was 
formulated. 
 
Null Hypothesis H05(a): 
There is no significant association between the post test level of 
patency of peripheral intravenous cannula among experimental group II 
(Normal saline) with their age. 
 
In order to test the hypothesis H5(a) the researcher used chi-square 
test. The following table shows the finding. 
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Table–4.11: Association of post-test (day 4) level of patency of 
peripheral intravenous cannula among experimental group II 
(Normal saline) with their age.                                              n=15 
S.NO 
Demographic    
variables 
Adequate                 
patency         
(0-1) 
Moderately 
adequate 
patency (2) 
Inadequate  
(3) 
Chi-square     
value 
(X 2) 
No % No % No  % 
I Age in years             
16.69*                                  
a) 21-30 1 6.7 0 0 1 6.7 
b) 31-40 5 33.33 1 6.7 0 0 
c) 41-50 5 33.33 0 0 0 0 
d) 51-60 0 0 2 13.33 0 0 
*level of significant p<0.05 level,  d.f = 6,   Table value = 12.59 
 
Data presented in table 4.11 Shows that calculated chi-square value 
is greater than the table value, which indicates that there is a significant 
association between the post test level of patency of peripheral 
intravenous cannula among experimental group II (Normal saline) with 
their age at p<0.05 level. Hence the hypothesis H5(a) was accepted and 
null hypothesis H05(a)  was rejected. 
 
b. Association of post-test (day 4) level of patency of peripheral 
intravenous cannula among experimental group II (Normal saline) 
with size of cannula. 
Hypothesis H5(b): 
There is a significant association between the post test levels of 
patency of peripheral intravenous cannula among experimental group II 
(Normal saline) with size of cannula. 
 
To test the hypothesis H5(b) the following null hypothesis H05(b) was 
formulated. 
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Null Hypothesis H05(b): 
There is no significant association between the post test level of 
patency of peripheral intravenous cannula among experimental group II 
(Normal saline) with size of cannula. 
The following table shows the finding. 
Table – 4.12: Association of post-test (day 4) level of patency of 
peripheral intravenous cannula among experimental group II 
(Normal saline) with size of cannula.                                         n=15 
S.NO 
Demographic    
variables 
Adequate                 
patency         
(0-1) 
Moderately 
adequate 
patency(2) 
Inadequate  
(3) Chi-square     
value(X 2) 
No % No % No  % 
II Size of cannula             
 0.828                                  
N.S 
a) 18G 1 6.7 0 0 0 0 
b) 20G 9 60.00 3 20.00 1 6.7 
c) 22G 1 6.7 0 0 1 6.7 
N.S - Not significant p<0.05 level of significance,  d.f=4    Table value = 9.49 
 
Data presented in table 4.12 Shows that calculated chi-square value 
is less than the table value, which indicates that there is no significant 
association between the post test level of patency of peripheral 
intravenous cannula among experimental group II (Normal saline) and 
size of cannula at p<0.05 level. Hence the hypothesis H5(b) was rejected  
and null hypothesis H05(b)  was accepted. 
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c. Association of post-test (day 4) level of patency of peripheral 
intravenous cannula among experimental group II (Normal saline) 
with site of cannula insertion 
Hypothesis H5(c): 
There is a significant association between the post test level of 
patency of peripheral intravenous cannula among experimental group II 
(Normal saline) with site of cannula insertion. 
 
To test the hypothesis H5(c) the following null hypothesis H05(c) was 
formulated. 
 
Null Hypothesis H05(c): 
There is no significant association between the post test level of 
patency of peripheral intravenous cannula among experimental group II 
(Normal saline) with site of cannula insertion. 
In order to test the hypothesis H5(c) the researcher used chi-square 
test. The following table shows the finding. 
 
Table–4.13: Association of post-test (day 4) level of patency of 
peripheral intravenous cannula among experimental group II 
(Normal saline) with site of cannula insertion.       n=15 
S.No 
Demographic    
variables 
Adequate                 
patency         
(0-1) 
Moderately 
adequate 
patency(2) 
Inadequate  
(3) Chi-square     
value(X 2) 
No % No % No  % 
III 
Site of cannula 
insertion             5.15                                  
N.S a Right Hand 1 6.7 2 13.33 0 0 
b Left Hand 10 66.67 1 6.7 1 6.7 
N.S - Not significant p<0.05 level of significance,  d.f=6     Table value = 12.59 
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Data presented in table 4.13 Shows that calculated chi-square value 
is less than the table value, which indicates that there is no significant 
association between the post test level of patency of peripheral 
intravenous cannula among experimental group II (Normal saline) and 
site of cannula insertion at p<0.05 level. Hence the hypothesis H5(c) was 
rejected and null hypothesis H05(c) was accepted. 
 
SUMMARY 
This chapter dealt with the analysis and interpretation of data on 
effectiveness of heparinised saline and normal saline in maintaining the 
patency of peripheral intravenous cannula. Here the distribution of 
demographic variables and score of patency of peripheral intravenous 
cannula was assessed. The hypothesis was tested and the association 
between mean post test score of patency of peripheral intravenous 
cannula with their demographic variable were found.  
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CHAPTER V 
 
DISCUSSION 
 
This chapter deals with the discussion of the major findings and 
recommendations in accordance with the objectives and hypothesis of the 
study. The problem statement was a comparative study to assess the 
effectiveness of heparinised saline and normal saline flush on patency of 
peripheral intravenous cannula among patients with medical conditions in 
selected hospital at Salem. 
 
The research design selected for the present study was quasi 
experimental post-test only control group design. The study consists of 45 
samples (15 in experimental group I, experimental group II, and Control 
group) who were admitted in Shanmuga hospital, Salem. 
 
5.1 Objective-1: To assess and compare the mean post test score of 
patency of peripheral intravenous cannula among Experimental 
group-I (Heparinised saline) and Control group. 
 In this study the researcher administered heparinised saline flush 
for experimental group I which consisting of 15 samples. The study was 
intended to evaluate the effectiveness of heparinised saline on patency of 
intravenous cannula among patients with medical conditions in selected 
hospital, Salem. The post test score of patency of intravenous cannula 
was assessed by using structured rating scale. 
 In the experimental group I, 15(100%) had adequate patency in day 
1. In day 2, majority 14(93.33%) had adequate patency and 
1(6.67%) had moderately adequate patency. In day 3, majority 
12(80%) had adequate patency and 3(20%) had moderately 
adequate patency. In day 4 majority 11(73.33%) had adequate 
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patency, 2(13.33%) had moderately adequate patency and 
2(13.33%) had inadequate patency.  
 In the control group, 15(100%) had adequate patency in day1. In 
day 2, majority 9(60%) had adequate patency, 3(20%) had 
moderately adequate patency and 3(20%) had inadequate patency 
and have undergone re-cannulation. Whereas in day 3, majority 
6(40%) had moderately adequate patency, 4(26.67%) had adequate 
patency and 5(33.3%) had inadequate patency and have undergone 
re-cannulation. In day 4, 9(60%) had inadequate patency, 3(20%) 
had moderately adequate patency and only 3(20%) had adequate 
patency.  
 
 The mean post test score of patency of peripheral intravenous 
cannula in experimental group I was 1.3 ± 0.7 and the mean score 
in control group was 2.07 ± 0.89. The calculated unpaired‘t’ value 
was t = 2.58 which was found to be statistically significant at p < 
0.05 level. The day 4 post test was taken to find the effectiveness 
of the intervention.  
 
The above results supported by the following study, Jonker M.A, 
Osterby KR, etal (2010) did a retrospective cohort study to assess the 
effectiveness of heparinised saline flush and normal saline flush in 
maintaining the patency of central venous  access devices over a one 
month period. The study result showed that the heparinised saline flush is 
effective in decreasing the thrombotic occlusions of central venous access 
devices than the normal saline flush. 
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5.2 Objective-2:  To assess and compare the mean post test score of 
patency of peripheral intravenous cannula among Experimental 
group-II (Normal saline) and Control group. 
In this study the researcher administered normal saline flush for 
experimental group II which consisting of 15 samples. The study was 
intended to evaluate the effectiveness of normal saline on patency of 
intravenous cannula among patients with medical conditions in selected 
hospital, Salem. The post test score of patency of intravenous cannula 
was assessed by using structured rating scale. 
 In experimental group II, 15(100%) had adequate patency in day 1. 
In day 2, majority 13(86.67%) had adequate patency and 
2(13.33%) had moderately adequate patency. In day 3, majority 
12(80%) had adequate patency and 3(20%) had moderately 
adequate patency. In day 4, majority 11(73.33%) had adequate 
patency, 3(20%) had moderately adequate patency and 1(6.67%) 
had inadequate patency. 
 
 In control group, 15(100%) had adequate patency in day1. In day 
2, majority 9(60%) had adequate patency, 3(20%) had moderately 
adequate patency and 3(20%) had inadequate patency and have 
undergone re-cannulation. Whereas in day 3, majority 6(40%) had 
moderately adequate patency, 4(26.67%) had adequate patency and 
5(33.3%) had inadequate patency and have undergone re-
cannulation. In day 4, 9(60%) had inadequate patency, 3(20%) had 
moderately adequate patency and only 3(20%) had adequate 
patency.  
 
 The mean post test score of patency of peripheral intravenous 
cannula in experimental group II was 1.2 ± 0.54 and the mean 
63 
 
score in control group was 2.07 ± 0.89. The calculated unpaired‘t’ 
value was t = 3.167 which was found to be statistically significant 
at p < 0.05 level. The day 4 post test was taken to find the 
effectiveness of the intervention.  
 
The above finding was supported by the study conducted by 
Heidari Gorji MA, et.al, (2015).  A double blind study on 84 patients of 
intensive care unit in Mazandaran University of Medical Sciences, Iran. 
The patients were randomly divided into two groups of heparinised saline 
and normal saline receivers. It is suggested that use of normal saline 
solution is effective in maintaining the patency of central venous 
catheters than the heparinised saline.  
 
Del Cotillo M, Grane N, et.al, (2008), conducted a double blind 
controlled clinical trial in intensive care unit of a hospital in Terrassa, 
Barcelona, Spain. In this study 133 patients were included (65 patients 
received heparinised saline solution and 68 patients received normal 
saline solution). The study result showed that the duration of catheter was 
5 days in heparin group and 5 and half days in saline group. So it is 
suggested that the use of normal saline solution is effective than 
heparinised saline solution. 
 
5.3 Objective-3: To assess and compare the mean post test score of 
patency of peripheral intravenous cannula between Experimental 
group-I and Experimental group-II. 
 In the experimental group I, 15(100%) had adequate patency in day 
1. In day 2, majority 14(93.33%) had adequate patency and 
1(6.67%) had moderately adequate patency. In day 3, majority 
12(80%) had adequate patency and 3(20%) had moderately 
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adequate patency. In day 4 majority 11(73.33%) had adequate 
patency, 2(13.33%) had moderately adequate patency and 
2(13.33%) had inadequate patency. 
 
 In experimental group II, 15(100%) had adequate patency in day 1. 
In day 2, majority 13(86.67%) had adequate patency and 
2(13.33%) had moderately adequate patency. In day 3, majority 
12(80%) had adequate patency and 3(20%) had moderately 
adequate patency. In day 4, majority 11(73.33%) had adequate 
patency, 3(20%) had moderately adequate patency and 1(6.67%) 
had inadequate patency. 
 
 The mean post test score of patency of peripheral intravenous 
cannula in experimental group I was 1.3 ± 0.7 and the mean score 
in experimental group II was 1.2 ± 0.54. The calculated unpaired‘t’ 
value was t = 0.43 which was found to be statistically not 
significant at p < 0.05 level. The day 4 post test was taken to find 
the effectiveness of the intervention. 
 
The above findings was supported by the study conducted by Rui 
wang, Ming-Guang Zhang, (2012), they did a prospective randomized, 
controlled, single- blinded trial to compare the effectiveness and safety of 
heparinised saline and normal saline as flushing and locking solutions for 
peripheral venous catheters in decompensated liver cirrhosis patients. A 
total of 32 – 36 patients were allocated to normal saline and heparinised 
saline respectively. The results showed that the maintenance times of the 
heparinised saline and the normal saline groups were 80.27 ± 26.47 and 
84.19 ± 29.32 hours respectively. The peripheral venous catheters 
occlusion rates were 6.2% and 5.6% in the heparinised saline and normal 
saline groups respectively. The researcher concluded that the normal 
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saline is as effective like heparin saline for flushing and locking the 
peripheral venous catheters. 
 
Schallom M.E, et.al, (2012), conducted a study in medical 
intensive care units at Barnes-Jewish hospital, St Louis to compare the 
effects of heparin and 0.9% normal saline flush solution for maintaining 
the central venous catheter lumen patency. Total 341 patients were 
randomly assigned to receive either heparin or 0.9% sodium chloride 
flush. The study results revealed that 0.9% sodium chloride and heparin 
flush solutions have similar rates of lumen patency. The researcher 
concluded that 0.9% saline seems to be as effective as heparinised 
solution for keeping patterned vascular devices. 
 
5.4 Objective-4: To find association between the post test levels of 
patency of peripheral intravenous cannula among the Experimental 
group-I and Experimental group-II with their selected demographic 
variables (Age, Size of cannula, site of cannula insertion). 
 In this study, the association was analysed by using chi-square 
between post test level of patency of peripheral intravenous cannula 
among patients with their selected demographic variables (Age, Size of 
cannula and Site of cannula insertion) in experimental group I 
(heparinised saline) and experimental group II (normal saline). The 
findings showed that there was no significant association between the 
post test level of patency of peripheral intravenous cannula in 
experimental group I (heparinised saline) with their age, size of cannula 
and site of cannula insertion at p < 0.05 level. But there is a significant 
association between the post test levels of patency of peripheral 
intravenous cannula in experimental group II (normal saline) with their 
age. 
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 Honnagouda Patil, L.M. Sames Gon, (2014), conducted a study 
in medical surgical wards of  A.J hospital and Research Centre, 
Mangalore. 40 samples were selected in that 20 were assigned to 
heparinised saline group and 20 were assigned to normal saline group. 
The study results showed that there is a significant association in between 
patency and purpose of therapy, gauge of cannula, length of cannula, site 
of cannula and drug administered at p > 0.05 level. 
 
Jeanette Robertson, (2011), did a randomized control trial in 152 
patients with the age of 2 months to 2 years, to determine the effect of 
normal saline on patency of intravenous cannula. Samples were randomly 
allocated to heparinised saline and normal saline group. The study result 
showed that the young children were found to have a significantly higher 
incidence of blocked cannulae regardless of flushing solution.  
 
SUMMARY 
This chapter dealt with the discussion of the research findings with 
supportive studies based on each objective. 
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CHAPTER-VI 
 
SUMMARY, MAJOR FINDINGS, IMPLICATIONS, 
RECOMMENDATIONS AND CONCLUSION 
  
 This chapter is divided into two sections.  In the first section the 
summary of the study, findings and conclusion are presented.  In the 
second section the suggestion and recommendations of study in the 
various areas of nursing like nursing education, nursing practice, nursing 
administration and nursing research is presented. 
 
6.1 SUMMARY OF THE STUDY 
 The major objective of the study was to assess the effectiveness of 
heparinised saline vs normal saline on patency of peripheral intravenous 
cannula in patients with medical conditions admitted in Shanmuga 
hospital. 
 
Imogene King’s Goal Attainment theory was selected as 
conceptual framework to assess the effectiveness of heparinised saline 
and normal saline flush on patency of peripheral intravenous cannula. A 
quantitative evaluative research approach with quasi experimental post-
test only control group design was adopted for this study. The samples 
were selected using non-probability purposive sampling technique. Total 
samples were 45, 15 in experimental group I, 15 in experimental group II 
and 15 in control group. 
 
The tools selected were demographic profile of the samples and 
structured rating scale to assess the patency of peripheral intravenous 
cannula. 
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Content validity was obtained from 6 experts (2 medical and 4 
nursing personnel). Reliability of tool was estimated by inter rater 
method. The score was ‘r’=0.98. The pilot study was conducted among 9 
samples in Gopi Hospital Salem. There was no modification done after 
pilot study. 
 
The study was conducted in Shanmuga hospital from 24.03.2016 to 
14.05.216. Initially the researcher got permission from the concerned 
authority after explaining the procedure and purpose of the study. The 
staff nurses of the Shanmuga hospital were oriented about the study and 
benefits of the heparinised saline and normal saline flush in maintaining 
the patency of peripheral intravenous cannula. Then the researcher 
selected 45 samples using non probability purposive sampling techniques. 
Written consent was obtained from the samples .The researcher has 
collected the data from control group then experimental group I 
(Heparinised saline) and at last from experimental group II (Normal 
saline). 
 
Selected interventions that are heparinised saline and normal saline 
flush were provided to the respective groups as per the plan. 
 
For experimental group I–Heparinised saline was used for 
maintaining the patency of peripheral intravenous cannula. It is prepared 
by adding 0.5ml of injection heparin in the strength of (5000 units in 5ml) 
with 100ml of normal saline. Now the prepared solution is having 2ml = 
10 unit’s heparin. Then the 2ml of heparinised saline is taken from the 
prepared solution and flushed into the intravenous cannula after the 
administration of prescribed medication twice daily (morning and 
evening) for 4 days from the first day and within 12 hrs of intravenous 
cannula insertion.  
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For experimental group II– Normal saline was used for 
maintaining the patency of peripheral intravenous cannula. Commercially 
available sterile 0.9% sodium chloride solution was used to flush the 
cannula. 2ml of saline is flushed into the peripheral intravenous cannula 
after the administration of prescribed medication twice daily (morning 
and evening) for 4 days from the first day and within 12 hrs of 
intravenous cannula insertion.  
 
Post test was conducted by using the structured rating scale to 
assess the patency of peripheral intravenous cannula twice daily for 4 
days from the first day. 
 
Finally, the data obtained was analysed in terms of the objectives 
and hypothesis of the study using descriptive and inferential statistics. 
 
6.2 MAJOR FINDINGS OF THE STUDY 
I. Demographic variables 
 Regarding the age of the samples in experimental group I majority 
6(40%) were in the age group of 41-50 years. In experimental 
group II majority 6(40%) were in the age group of 31 – 40 years. In 
control group majority 7(46.67%) were in the age group of 41 – 50 
years 
 Regarding the gender of the sample in experimental group I 
majority 8(53.33%) were male. In experimental group II majority 
9(60%) were male. In control group majority 8(53.33%) were 
female. 
 
 Regarding the educational status in experimental group I majority 
6(40%) had primary education. In experimental group II majority 
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6(40%) had higher secondary education. In control group majority 
7(46.67%) had higher secondary education. 
 
 Regarding the ward in experimental group I majority 8(53.33%) 
were admitted in Male medical ward. In experimental group II 
majority 9(60%) were admitted in Male medical ward. In control 
group majority 8(53.33%) were admitted in female medical ward. 
 
 Regarding the patient status in experimental group I majority 
7(46.67%) were in the status of bed mobility. In experimental 
group II majority 8(53.33%) were in the status of bed mobility. In 
control group majority 7(46.67%) were in the status of bed 
mobility. 
 
 Regarding the number of hospitalization in experimental group I 
majority 7(46.67%) were admitted for the first time. In 
experimental group II majority 6(40%) were admitted for the first 
time. In control group majority 6(40%) were admitted for the first 
time. 
 
 Regarding the size of cannula in experimental group I majority 
11(73.33%) had 20G as size of intravenous cannula. In 
experimental group II majority 13(86.67%) had 20G as size of 
intravenous cannula. In control group majority 12(80%) had 20G 
as size of intravenous cannula. 
 
 Regarding the site of cannula insertion in experimental group I 
majority 11(73.33%) had intravenous cannulation in left hand. In 
experimental group II majority 12(80%) had intravenous 
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cannulation in left hand. In control group majority 12(80%) had 
intravenous cannulation in left hand. 
 
 Regarding the classification of drug all 15(100%) in experimental 
group I, experimental group II and control group had antibiotics 
and antacids. 
 
II. Findings related to level of patency of peripheral intravenous 
cannula 
 In the experimental group I, 15(100%) had adequate patency in day 
1. In day 2, majority 14(93.33%) had adequate patency and 
1(6.67%) had moderately adequate patency. In day 3, majority 
12(80%) had adequate patency and 3(20%) had moderately 
adequate patency. In day 4 majority 11(73.33%) had adequate 
patency, 2(13.33%) had moderately adequate patency and 
2(13.33%) had inadequate patency. 
 
 In the experimental group II, 15(100%) had adequate patency in 
day 1. In day 2, majority 13(86.67%) had adequate patency and 
2(13.33%) had moderately adequate patency. In day 3, majority 
12(80%) had adequate patency and 3(20%) had moderately 
adequate patency. In day 4, majority 11(73.33%) had adequate 
patency, 3(20%) had moderately adequate patency and 1(6.67%) 
had inadequate patency. 
 
 In the control group, 15(100%) had adequate patency in day1. In 
day 2, majority 9(60%) had adequate patency, 3(20%) had 
moderately adequate patency and 3(20%) had inadequate patency. 
Whereas in day 3, majority 6(40%) had moderately adequate 
patency, 4(26.67%) had adequate patency and 5(33.3%) had 
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inadequate patency. In day 4, 9(60%) had inadequate patency, 
3(20%) had moderately adequate patency and 3(20%) had adequate 
patency. 
 
III. Findings related to effectiveness of heparinised saline and normal 
saline flush on patency of peripheral intravenous cannula. 
 Experimental group I and control group - The mean post test 
score of patency of peripheral intravenous cannula in experimental 
group I was 1.3 ± 0.7 and the mean score in control group was 2.07 
± 0.89. The calculated unpaired‘t’ value was t = 2.58 which was 
found to be statistically significant at p < 0.05 level. The above 
finding clearly indicates that there was significant difference in the 
level of patency of peripheral intravenous cannula in the 
experimental group I after the administration of heparinised saline 
and the control group. 
 
 Experimental group II and control group - The mean post test 
score of patency of peripheral intravenous cannula in experimental 
group II was 1.2 ± 0.54 and the mean score in control group was 
2.07 ± 0.89. The calculated unpaired‘t’ value was t = 3.167 which 
was found to be statistically significant at p < 0.05 level. The above 
finding clearly indicates that there was significant difference in the 
level of patency of peripheral intravenous cannula in the 
experimental group II after the administration of normal saline and 
the control group. 
 
 Experimental group I and experimental group II - The mean 
post test score of patency of peripheral intravenous cannula in 
experimental group I was 1.3 ± 0.7 and the mean score in 
73 
 
experimental group II was 1.2 ± 0.54. The calculated unpaired‘t’ 
value was t = 0.43 which was found to be statistically not 
significant at p < 0.05 level. The above finding clearly indicates 
that there was no significant difference in the level of patency of 
peripheral intravenous cannula in the experimental group I after the 
administration of heparinised saline and the experimental group II 
after the administration of normal saline. Hence the both have same 
effect in maintaining the patency of peripheral intravenous cannula. 
 
IV. Findings related to post test level of patency of peripheral 
intravenous cannula in experimental group I and experimental group 
II with their selected demographic variables. 
Experimental group I 
 The chi-square value of post test level of patency of peripheral 
intravenous cannula with age among samples is (3.98) which is less 
than the table value (12.59) which indicates no significant 
association at p < 0.05 level of significance. 
 
 The chi-square value of post test level of patency of peripheral 
intravenous cannula among samples and size of cannula is (3.15) 
which is less than the table value (9.49) which indicates no 
significant association at p < 0.05 level of significance. 
 
 The chi-square value of post test level of patency of peripheral 
intravenous cannula among samples and site of cannula insertion is 
(0.84) which is less than the table value (12.59) which indicates no 
significant association at p < 0.05 level of significance. 
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Experimental group II  
 The chi-square value of post test level of patency of peripheral 
intravenous cannula with age among samples is (16.69) which is 
greater than the table value (12.59) which indicates there is a 
significant association between age and patency of peripheral 
intravenous cannula in normal saline group at p < 0.05 level of 
significance. 
 
 The chi-square value of post test level of patency of peripheral 
intravenous cannula among samples and size of cannula is (0.828) 
which is less than the table value (9.49) which indicates no 
significant association at p < 0.05 level of significance. 
 
 The chi-square value of post test level of patency of peripheral 
intravenous cannula among samples and site of cannula insertion is 
(5.15) which is less than the table value (12.59) which indicates no 
significant association at p < 0.05 level of significance. 
 
6.3 IMPLICATIONS 
 The findings of the study have implication in various areas of 
nursing like nursing practice, nursing education, nursing administration 
and nursing research. 
 
6.3.1 Nursing Practice 
 A Nurse plays an important role in caring the intravenous 
cannulation site for prolonging the life and to prevent the complications 
occurring due to intravenous cannulation and improper maintenance. The 
key aim of the study was to maintain the patency of peripheral 
intravenous cannula. The finding of the study clearly states that the 
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administration of heparinised saline and normal saline are effective in 
maintaining the patency of peripheral intravenous cannula. 
 
The nurses can be encouraged for the use of heparinised saline or 
normal saline according to the hospital protocol to maintain the patency 
of cannula which will reduce the work load of cannula removal and re 
inserting again. Also it will reduce the cost of cannula purchase for the 
hospital as well as to the patients. 
 
6.3.2 Nursing Education 
The nursing curriculum should emphasize on the various methods 
for maintaining the patency of peripheral intravenous cannula.  
 
Present study proved that the heparinised saline and normal saline 
has same effect in maintaining the patency of peripheral intravenous 
cannula. The purpose and importance of maintaining the patency and 
preventing the intravenous cannula related complications and use of 
normal saline and heparinised saline should be taught to the student 
nurses, which will be helpful to the nurses in preventing the occurrence of 
complications in the hospital settings. 
 
6.3.3 Nursing Administration 
The nursing administration of the hospital should take a major step 
toward educating the nurses of the hospital about prevention of 
intravenous cannula related complications and maintenance of patency of 
intravenous cannula among the patients. This study helps the nurse 
administrator to formulate adequate policies in adopting the practice of 
administration of heparinised saline or normal saline among the nurses 
which will enable the patient in preventing the complications and 
76 
 
maintaining the patency and also reducing the manpower, money, 
material, method and time of the hospital as well as the nurse and the 
patient. The ward nurses should be provided with the heparinised or 
normal saline solution and explanation about how to administer to the 
patient along with the rationale for the uses given by the nursing 
administration department of the hospital. Also the nurse administrator 
has to insist the hospital management for developing standard protocol 
regarding intravenous line management and flushing technique. 
 
Sufficient study materials must be supplied to the nurses and they 
must be encouraged to read about the articles related to complications 
that are occurring due to intravenous cannulation and improper 
management of cannulation site and also its prevention using heparinised 
saline and normal saline. In service education can be conducted for the 
nurses. Research findings can be utilized in clinical practice. The nurses 
in the hospital should be properly educated by providing training and 
encouraging them to apply the research findings in daily practice by the 
nurse administration.  
 
6.3.4 Nursing Research 
The study showed that there is a lack of practice for maintaining 
the patency of peripheral intravenous cannula and for prevention of 
cannula induced complications. It indicates there is a need for the 
research in assessing the effectiveness of heparinised saline and normal 
saline administration for maintaining the patency of peripheral 
intravenous cannula. Hence the nursing staffs and students should be 
encouraged to conduct research needed in maintaining the patency and 
reducing the occurrence of complications due to intravenous cannula.  
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Present study helps the nursing personnel to develop inquiry by 
providing a base for the further research in different settings. There is a 
need for extensive and intensive research focusing nursing staffs, so that 
strategies can be made to educate the nursing personnel about the 
importance of preventing the intravenous cannulation induced 
complications and maintaining the patency of intravenous cannula. 
 
6.4 RECOMMENDATIONS 
1. Similar study can be conducted in different settings. 
2. Similar study can be replicated to a large sample for generalization. 
 
6.5 LIMITATIONS 
1. Few of the samples got discharged in between the data collection 
period, so they were considered as attrition of the study. 
2. Re-cannulation was done for few samples on second, third day and 
fourth day in control group which might have influenced the result 
of the study. 
 
6.6 CONCLUSION 
In this study heparinised saline and normal saline are have the 
same effect in maintaining the peripheral intravenous cannula. Normal 
saline is effective in maintaining the patency of peripheral intravenous 
cannula as it is commercially available, cost effective and no need of 
specific preparation methods. Awareness of nursing staffs about these 
flushing solutions can prevent the complications and will maintain the 
patency of cannula. Considering the cost effective care the nurses can be 
encouraged to use normal saline as a flush solution in practice. Due to the 
administration of normal saline the patient will have less pain on 
cannulation site and also will maintain the patency of cannula. This 
method of maintaining the patency of cannula will reduce the financial 
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burden of the patients from buying intravenous cannula again and again. 
It will also help in cost containment of intravenous cannula supply in 
hospitals and reduces the work load of the nurses in terms of reinserting 
the intravenous cannula to the patients. 
 
SUMMARY 
This chapter dealt with summary, implications, recommendations 
and conclusion of the study. 
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ANNEXURE –I 
LETTER SEEKING PERMISSION TO CONDUCT RESEARCH 
STUDY 
From, 
 N. Rajalakshmi, 
II-Year M.Sc., (N) student, 
Shanmuga College of Nursing, 
24, Saradha college road, 
Salem-636007. 
 
To, 
The chairman,  
Shanmuga Hospital, 
Salem - 636007. 
 
Through 
 The Principal, 
 Shanmuga College of Nursing, 
 24, Saradha college road, 
 Salem -636007. 
 
Respected Sir/Madam 
 Sub: Requesting permission for conduct research study 
 I, N. Rajalakshmi, II Year M.Sc.,(N) student of Shanmuga College of Nursing 
Salem, forthe partial fulfilmentof M.Sc.,(N) programme, have undertaken the 
following research study, which has to be submitted to the Dr.M.G.R. Medical 
University, Chennai. 
STATEMENT OF THE PROBLEM 
“A comparative study to evaluate the efficacy of heparinised saline and 
normal saline flush on patency of peripheral intravenous cannula among 
patients with medical conditions in selected hospital at Salem. 
In this regard, I seek permission to conduct the study in your hospital. I assure 
my presence will not disturb the routine functions in hospital. 
    Thanking you in anticipation, 
 
Place: Salem        Your’s faithfully 
Date:           
                    (N. Rajalakshmi)
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ANNEXURE –II 
LETTER SEEKING OPINION FOR CONTENT VALIDITY OF 
TOOL AND INDEPENDENT VARIABLE 
From 
 N. Rajalakshmi 
 II-Year M.Sc., (N) student, 
 Shanmuga College of Nursing,  
 24, Saradha college road, 
Salem- 636007. 
To 
 
Through 
 The Principal, 
 Shanmuga College of Nursing, 
 24, Saradha college road, 
 Salem – 636007. 
Respected Sir/Madam, 
 Sub: Expert opinion on content validity of the tool 
I, N. Rajalakshmi II year M.Sc., (N) student of Shanmuga College of Nursing 
Salem, for the partial fulfilment of M.Sc.,(N) programme, have undertaken the 
following research study, which has to be submitted to the M.G.R.Medical University, 
Chennai. I am conducting “A comparative study to evaluate the efficacy of 
heparinised saline and normal saline flush on patency of peripheral intravenous 
cannula among patients with medical conditions in selected hospital at Salem.  
So I humbly request you to give your valuable suggestions regarding the 
appropriateness of the tool and independent variable. 
I also request you to kindly sign the certificate stating that you have validated 
the tool.  
Thanking you, 
Place: Salem       Yours Faithfully, 
 
Date:        (N. Rajalakshmi)  
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ANNEXURE –III 
LIST OF EXPERTS WHO VALIDATED THE TOOL AND 
INDEPENDENT VARIABLES 
 
1. Dr.  R. Murugavel, MS, 
General Surgeon, 
Shanmuga Hospital, 
Salem. 
2. Dr. P. Prabusankar, MS, MRCS 
General surgeon, 
Shanmuga Hospital, 
Salem. 
3. Dr. S. Punitha Josephine, Ph.D., 
Vice Principal, 
Dept of Medical Surgical Nursing, 
KarpagaVinayaga College of Nursing, 
Kanchipuram. 
4. Mrs. M. Geetha, M.Sc(N)., 
Principal, 
Vivekanandha Nursing College for Women, 
Veerachipalayam,  
Sankari. 
5. Mrs. P. Neela, M.Sc(N), 
Vice Principal, 
Dept of Medical Surgical Nursing, 
Swami Vivekanandha College of Nursing, 
Dharmapuri. 
6. Mrs. R. Ruckmani, M.Sc(N)., 
Associate Professor, 
Dept of Medical Surgical Nursing, 
Aravind College of Nursing, 
Namakkal. 
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ANNEXURE - IV 
EVALUATION CRITERIA FOR THE CONTENT VALIDITY OF 
TOOLS / INDEPENDENT VARIABLES 
Respected Sir/Madam, 
I kindly request you to go through the table and give your valuable 
response and suggestion in the respective column given in the criterion 
table which helps me in modifying the tool. 
TOOL: I DEMOGRAPHIC VARIABLES 
S. No Items Yes No Remarks 
1 Age in years       
       a) 20-30       
       b) 31-40       
       c) 41-50       
       d) 51-60       
2 Gender       
       a) Male       
       b) Female       
3 Educational Status       
       a) No formal education       
       b) Primary education       
       c) Higher secondary        
       d) Graduate & above       
4 Ward       
       a) Male Medical ward       
       b) Female Medical ward       
5 Patient status       
       a) Bed ridden       
  b) Movement only in the cot       
  c) Complete ambulation       
v 
 
6 Number of hospitalization       
       a) 1st time       
       b) 2nd time       
       c) 3rd time       
       d) More than 3 times       
7 Size of cannula       
       a) 18 G       
       b) 20 G       
       c) 22 G       
8 Site of intravenous cannula       
       a) Right hand       
       b) Left hand       
       c) Right leg       
       d) Left leg       
9 Classification of drug infused       
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TOOL - II 
STRUCTURED RATING SCALE TO ASSESS THE PATENCY OF 
INTRAVENOUS CANNULATION SITE 
 
Instructions:  
The researcher assesses the intra venous site daily and put (√) mark 
at the appropriate score in the column given for four days. 
S. No Site Observation Score Yes No  Remarks 
1 Intravenous Site appears healthy 
No pain 
No redness 
No swelling 
0 
      
2 Slight Pain around the IV site 
1 
      
Slight Skin redness/blanching 
around the IV site 
3 Along with symptoms of score 1         
Tenderness along the path of 
cannula 
2 
      
Swelling around the Iv site 
Warmth/Coolness around the Iv 
site 
Tightness around the Iv site 
Pain along the path of the cannula 
4 Along with symptoms of score 1 
and 2         
Slow flow of medication 
3 
      
Resistance while administering 
medicine 
Leaking from IV site 
Palpable venous card 
Complete blockage while 
administering medicine 
 Maximum Score 3 
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SCORING  
ADEQUATE PATENCY   - 0 – 1 
MODERATE PATENCY  - 2 
INADEQUATE PATENCY   - 3 
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EVALUATION CRITERIA FOR THE CONTENT VALIDITY OF 
INDEPENDENT VARIABLES 
Respected Sir/Madam, 
 Kindly go through the content of procedure for administration of 
heparin saline and normal saline flush in the intravenous line. I kindly 
request you to give your suggestions on the content of procedure which 
will be helpful for me in modifying the procedure. 
S.No Criteria Yes No Remarks 
 Administration of heparinised 
saline and normal saline flush 
   
1. Whether it has covered the 
entire procedure 
   
2. Whether the procedure is 
appropriate 
   
3. Whether the procedure is 
adequate 
   
4. 
 
Whether it is relevant to the 
topic 
   
5. Whether arranged in sequence    
6. Whether arranged in logical 
order 
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ANNEXURE - V 
PERCENTAGE OF AGREEMENT/ DISAGREEMENT (VALIDITY OF TOOL) 
TOOL I: DEMOGRAPHIC VARIABLES 
S.No Items % of agree % of disagree Remarks 
1 Age in years 
100% 
  
Retained 
       a) 20-30 
       b) 31-40 
       c) 41-5 
       d) 51-60 
2 Gender 
80% 20% Modified Added 
transgender 
       a) Male 
       b) Female 
3 Educational Status 
100% 
  
Retained 
       a) No formal education 
       b) Primary education 
       c) Higher secondary  
       d) Graduate&above 
x 
 
4 Ward 
100% 
  
Retained        a) Male Medical ward 
       b) Female Medical ward 
5 Patient status 
80% 20% 
Modified the term as  
Confined to bed and            
Bed mobility 
       a) Confined to bed 
       b) Bed Mobility 
       c) Complete ambulation 
6 Number of hospitalization 
100% 
  
Retained 
       a) First time 
       b) Second time 
       c) Third time 
       d) More than 3 times 
 
7 Size of cannula 
100% 
  
  
       a) 18 G   
       b) 20 G Retained 
       c) 22 G   
xi 
 
8 Site of intravenous cannula 
100% 
  
Retained 
       a) Right hand 
       b) Left hand 
       c) Right leg 
       d) Left leg 
9 Classification of the drug infused 100%   Retained 
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TOOL – II 
STRUCTURED RATING SCALE TO ASSESS THE PATENCY OF INTRAVENOUS CANNULATION SITE 
Instructions:  
The researcher assesses the intra venous site daily and put (√) mark at the appropriate score in the column given for 
four days. 
S. No Site Observation Score 
% of 
agree % of disagree Remarks 
1 Intravenous Site appears healthy 
No pain 
No redness 
No  swelling 
0 100% 
  
Retained 
2 Slight Pain around the IV site 
1 100% 
  
Retained 
Slight Skin redness/blanching around the IV site 
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3 Along with symptoms of score 1 
 
2 
  
  
  
  
Tenderness along the path of cannula 
100% Retained 
Swelling around the Iv site 
Warmth/Coolness around the Iv site 
Tightness around the Iv site 
Pain along the path of the cannula 
4 Along with symptoms of score 1 and 2         
Slow flow of medication 
3 80% 20% 
Modified 
Removed 
Fever  
Resistance while administering medicine 
Leaking from IV site 
Palpable venous card 
Complete blockage while administering medicine 
Fever 
 Maximum Score 3    
SCORING  
 ADEQUATE PATENCY   - 0 – 1 
 MODERATE PATENCY  - 2 
 INADEQUATE PATENCY   - 3 
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ANNEXURE - VI 
CONTENT VALIDITY CERTIFICATE 
 
 I hereby certify that I have validated the tool of N. Rajalakshmi, 
M.Sc.,(N)student of Shanmuga College of Nursing at Salem, who is 
undertaking,“A comparative study to evaluate the efficacy of 
heparinised saline and normal saline flush on patency of peripheral 
intravenous cannula among patients with medical conditions in 
selected hospital at Salem”. 
 
 
 Signature ofExpert 
 Name: 
 Designation: 
Place: 
Date: 
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ANNEXURE – VII 
TOOL -I 
DEMOGRAPHIC PROFILE 
Instructions    
 The samples are requested to give some information about them. 
The response will be ticked by the researcher. The response will be kept 
confidential and it will be used for this study purpose only.  
         Sample No:  
1. Age in years :  
a. 20 – 30        [  ] 
b. 31 – 40        [  ]  
c. 41 – 50        [  ] 
d. 51 – 60        [  ] 
2. Gender :  
a. Male         [  ] 
b. Female        [  ] 
c. Transgender        [  ] 
3. Educational Status : 
a. No formal education      [  ] 
b. Primary education       [  ]  
c. Higher secondary       [  ] 
d. Graduate & above       [  ] 
4. Ward : 
a. Male Medical ward      [  ] 
b. Female Medical ward      [  ] 
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5. Patient Status : 
a. Confined to bed       [  ] 
b. Bed mobility       [  ] 
c. Complete ambulation      [  ] 
6. Number of Hospitalization : 
a. First time        [  ] 
b. Second time        [  ] 
c. Third time        [  ] 
d. More than 3 times       [  ] 
7. Size of Cannula :  
a. 18G        [  ] 
b. 20G        [  ] 
c. 22G        [  ] 
8. Site of Intravenous cannula inserted:  
d. Right hand       [  ] 
e. Left hand       [  ] 
f. Right leg        [  ] 
g. Left leg        [  ] 
 
9. Classification of Drug infused : _________________________ 
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TOOL – II 
STRUCTURED RATING SCALE TO ASSESS THE PATENCY OF INTRAVENOUS CANNULATION SITE 
Instructions: 
The researcher assesses the intra venous site daily and put (√) mark at the appropriate score in the column given for 
four days. 
S.No Site Observation Score Day1 Day2 Day3 Day4 
   M E M E M E M E 
1 No symptoms 0         
2 Slight Pain around the IV site 
Slight Skin redness/blanching around the IV site 
1 
        
3 Along with symptoms of score 1 
Tenderness along the path of cannula 
Swelling around the Iv site 
Warmth/Coolness around the Iv site 
Tightness around the Iv site 
Pain along the path of the cannula 
 
2 
        
xviii 
 
4 Along with symptoms of score 1 and 2 
Slow flow of medication 
Resistance while administering medicine 
Leaking from IV site 
Palpable venous card 
Complete blockage while administering medicine 
3 
        
 MAXIMUM SCORE 3         
 
SCORING  
 ADEQUATE PATENCY   - 0 – 1 
 MODERATE PATENCY  - 2 
 INADEQUATE PATENCY   - 3 
 
xix 
 
ANNEXURE –VIII 
INDEPENDENT VARIABLES 
HEPARINISED SALINE AND NORMAL SALINE FLUSH 
Purposes 
1. To maintain the adequate patency of intravenous line cannula. 
2. To provideintravenous line cannula care to the patient. 
3. To prevent complications of intra venous line cannulation. 
4. To prolong the life of intravenous line cannula. 
 
Preliminary assessment 
1. Observe the condition of the patient. 
2. Check the cannulation insertion site weather it is clean or any 
leakage is present. 
3. Inspect the site of cannula insertion for complications  such as 
thrombophlebitis, infiltration, block etc., 
 
Preparation of the patient  
1. Provide privacy for the patient 
2. Provide information to patient regarding intravenous line cannula 
care. 
3. Get consent from patient. 
 
HEPARINISED SALINE FLUSH 
Articles 
1. Soap and soap dish for hand washing. 
2. Sterile gloves. 
3. Sodium chloride (0.9%) solution-100ml Bottle with top 
covering.(1) 
4. Inj. Heparin (5000I.U in 5ml).(1vial) 
xx 
 
5. Sterile syringe(2ml) with protective covering. (2) 
6. Small mackintosh.(1) 
7. Steel bowl with dry cotton swaps.(1) 
8. Kidney tray.(1) 
 
Procedure 
1. Wash hands. 
2. Prepare the heparinised saline solution. (Take 0.5ml of heparin 
from vial which is in the strength of (5000 I.U in 5ml) and add with 
100ml of 0.9% sodium chloride solution, now 1ml of solution 
contains 5 units heparin). 
3. Mix the solution well and take 2ml of prepared solution with 
aseptic manner in a sterile 2ml syringe. 
4. Flush the intravenous line cannula with 2ml of heparinised saline 
twice daily (morning and evening) after administration of 
prescribed medication for experimental group I starting from 
within 12hrs of intravenous cannulation for 4 days. 
5. Check for resistance, leakage and complete blockage 
6. Instruct the patient (or) care taker to report if there is any pain, 
swelling, redness, etc. 
7. Collect all the used articles replace properly and dispose the waste 
appropriately. 
8. Wash hands. 
9. Document the procedure (Date, time, condition of vein) with 
signature. 
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NORMAL SALINE FLUSH 
Articles 
1. Soap and soap dish for hand washing. 
2. Sterile gloves. 
3. Sodium chloride(0.9%) solution-100ml Bottle with top 
covering.(1) 
4. Sterile syringe (2ml) with protective covering. (2) 
5. Small mackintosh.(1) 
6. Steel bowl with dry cotton swaps.(1) 
7. Kidney tray.(1) 
 
Procedure 
1. Wash hands. 
2. Take 2ml of sodium chloride (0.9%) solution from the bottle with 
aseptic manner in a sterile 2ml syringe. 
3. Flush the intravenous line cannula with 2ml of solution twice daily 
(morning and evening) after administration of prescribed 
medication for experimental group II starting from within 12hrs of 
intravenous cannulation for 4 days. 
4. Check for resistance, leakage and complete blockage. 
5. Instruct the patient (or) care taker to report if there is any pain, 
swelling, redness, etc. 
6. Collect all the used articles replace properly and dispose the waste 
appropriately. 
7. Wash hands. 
8. Document the procedure (Date, time, condition of vein) with 
signature. 
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ANNEXURE–IX 
 
CONSENT FORM 
 
I, N. Rajalakshmi, II year M.Sc. Nursing student of Shanmuga 
College of Nursing, as a part of my M.Sc. Nursing programme have 
selected a research topic on “A COMPARATIVE STUDY TO 
EVALUATE THE EFFICACY OF HEPARINISED SALINE AND 
NORMAL SALINE FLUSH TO ASSESS THE PATENCY OF 
PERIPHERAL INTRAVENOUS CANNULA AMONG PATIENTS 
WITH MEDICAL CONDITIONS IN SELECTED HOSPITAL AT 
SALEM”. For which I would like to include you as the study samples. I 
ensure you that the details collected will be kept confidential and will be 
utilized only for this research purpose. 
Yours faithfully, 
 
(N. Rajalakshmi) 
The researcher has explained me in detail about the study and its 
benefits and no risk, and I came to know that I can withdraw from study 
at any time. She ensured that the information collected from me will be 
kept confidential and it is used only for this study. I am willing to be a 
sample for this study. 
        Yours faithfully, 
 
                                                                                        Signature: 
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rk;ke;jg;gotk; 
 e.,uh$yl;Rkp Mfpa ehd; rz;Kfh brtpypah; 
fy;Y}hpapy; ,uz;lhk; Mz;L KJfiy brtpypah; gl;lg;gog;g[ 
gof;Fk; khztp.. vdJ gog;gpd; xU gFjpahf Muha;r;rp 
xd;W fPH;fz;l jiyg;gpy; bra;a cs;nsd;. kUj;Jtkidapy; 
nehahspfSf;F nghlg;gLk; ,uj;jFHha; Crpapy; Vw;gLk; 
milg;g[f;F (bQg;ghpd; kw;Wk; ehh;ky; riyd;) Mfpa ,uz;L 
tHp Kiwfis gad;gLj;jp mjdhy; Vw;gLk; Kf;fpa gpd; 
tpist[fisg; gw;wp Muha;r;rp nkw;bfhs;s cs;nsd;. ,jpy; 
jh';fs; g';Fbfhs;SkhW jhH;ika[ld; nfl;Lf; bfhs;fpnwd;. 
nrfhpf;fg;gLk; tpgu';fs; ,ufrpakhfg; ghJfhf;fg;gLk; 
kw;Wk; Muha;;r;rpf;fhf kl;Lnk gad;gLj;jg;gLk; vd 
cWjpaspf;fpnwd;. 
,g;gof;F 
 
e.,uh$yl;Rkp 
  
kUj;Jtkidapy; nehahspfSf;F nghlg;gLk; ,uj;jFHha; 
Crpapy; Vw;gLk; milg;g[f;F (bQg;ghpd; kw;Wk; 
ehh;ky; riyd;) Mfpa ,uz;L tHpKiwfis cgnahfg;;gLj;jp 
nehahspfSf;F Vw;gLk; typ/ tPf;fk;/ kUe;J brYj;Jk;nghJ 
Vw;gLk; milg;g[ Mfpatw;iw xg;gPL bra;jiyg; gw;wp 
e.,uh$yl;Rkp Muha cs;sjhf mwpe;Jbfhz;nld;. Vdnt 
mtuJ Muha;r;rpapy; ehd; g';nfw;f KGkdJld; 
rk;kjpf;fpnwd;.  
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